Strain identifier
BacDive ID: 23294
Type strain:
Species: Staphylococcus aureus
Strain Designation: RN4220
Strain history: <- M. Mosa, IMUNA s.r.o., Praha, Czech Republic <- J. Doskar, Masaryk Univ., Faculty of Science, Brno, Czech Republic <- F. Götz, Univ. Tübingen <- R. P. Novick <- B. Kreisworth and S. Lofdahl
NCBI tax ID(s): 1280 (species)
General
@ref: 18922
BacDive-ID: 23294
DSM-Number: 26309
keywords: genome sequence, Bacteria, mesophilic, human pathogen
description: Staphylococcus aureus RN4220 is a mesophilic human pathogen that was isolated from laboratory research strain originally derived from NCTC 8325-4 using UV and chemical mutagenesis.
NCBI tax id
- NCBI tax id: 1280
- Matching level: species
strain history
- @ref: 18922
- history: <- M. Mosa, IMUNA s.r.o., Praha, Czech Republic <- J. Doskar, Masaryk Univ., Faculty of Science, Brno, Czech Republic <- F. Götz, Univ. Tübingen <- R. P. Novick <- B. Kreisworth and S. Lofdahl
doi: 10.13145/bacdive23294.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/bacillota
- domain: Bacteria
- phylum: Bacillota
- class: Bacilli
- order: Caryophanales
- family: Staphylococcaceae
- genus: Staphylococcus
- species: Staphylococcus aureus
- full scientific name: Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980)
synonyms
- @ref: 20215
- synonym: Staphylococcus aureus subsp. anaerobius
@ref: 18922
domain: Bacteria
phylum: Firmicutes
class: Bacilli
order: Bacillales
family: Staphylococcaceae
genus: Staphylococcus
species: Staphylococcus aureus
full scientific name: Staphylococcus aureus Rosenbach 1884
strain designation: RN4220
type strain: no
Culture and growth conditions
culture medium
- @ref: 18922
- name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92)
- growth: yes
- link: https://mediadive.dsmz.de/medium/92
- composition: Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water
culture temp
- @ref: 18922
- growth: positive
- type: growth
- temperature: 37
- range: mesophilic
Physiology and metabolism
metabolite utilization
@ref | Chebi-ID | metabolite | utilization activity | kind of utilization tested |
---|---|---|---|---|
68375 | 16199 | urea | - | hydrolysis |
68375 | 29016 | arginine | + | hydrolysis |
68375 | 18257 | ornithine | - | degradation |
68375 | 4853 | esculin | - | hydrolysis |
68375 | 17634 | D-glucose | + | fermentation |
68375 | 15824 | D-fructose | + | fermentation |
68375 | 16024 | D-mannose | + | fermentation |
68375 | 17306 | maltose | + | fermentation |
68375 | 17716 | lactose | + | fermentation |
68375 | 27082 | trehalose | + | fermentation |
68375 | 16899 | D-mannitol | + | fermentation |
68375 | 16634 | raffinose | - | fermentation |
68375 | 16988 | D-ribose | - | fermentation |
68375 | 17057 | cellobiose | - | fermentation |
68375 | 17632 | nitrate | + | reduction |
68375 | 17992 | sucrose | + | fermentation |
68375 | 59640 | N-acetylglucosamine | + | fermentation |
68375 | 32528 | turanose | + | fermentation |
68375 | 22599 | arabinose | - | fermentation |
antibiotic resistance
- @ref: 68375
- ChEBI: 28368
- metabolite: novobiocin
- is antibiotic: yes
- is resistant: yes
- resistance conc.: 1.8 µg
metabolite production
- @ref: 68375
- Chebi-ID: 15688
- metabolite: acetoin
- production: yes
metabolite tests
- @ref: 68375
- Chebi-ID: 15688
- metabolite: acetoin
- voges-proskauer-test: +
enzymes
@ref | value | activity | ec |
---|---|---|---|
68375 | beta-glucuronidase | - | 3.2.1.31 |
68375 | pyrrolidonyl arylamidase | - | 3.4.19.3 |
68375 | alkaline phosphatase | + | 3.1.3.1 |
68375 | L-arginine arylamidase | - | |
68375 | beta-galactosidase | - | 3.2.1.23 |
68375 | beta-glucosidase | - | 3.2.1.21 |
68375 | ornithine decarboxylase | - | 4.1.1.17 |
68375 | arginine dihydrolase | + | 3.5.3.6 |
68375 | urease | - | 3.5.1.5 |
API ID32STA
@ref | URE | ADH Arg | ODC | ESC | GLU | FRU | MNE | MAL | LAC | TRE | MAN | RAF | RIB | CEL | NIT | VP | beta GAL | ArgA | PAL | PyrA | NOVO | SAC | NAG | TUR | ARA | beta GUR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
18922 | - | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | + | + | + | + | - | - |
Isolation, sampling and environmental information
isolation
- @ref: 18922
- sample type: laboratory research strain originally derived from NCTC 8325-4 using UV and chemical mutagenesis
isolation source categories
Cat1 | Cat2 | Cat3 |
---|---|---|
#Engineered | #Laboratory | |
#Host | #Microbial | #Bacteria |
Safety information
risk assessment
- @ref: 18922
- pathogenicity human: yes
- pathogenicity animal: yes
- biosafety level: 2
- biosafety level comment: Risk group (German classification)
Sequence information
Genome sequences
@ref | description | accession | assembly level | database | NCBI tax ID |
---|---|---|---|---|---|
66792 | Staphylococcus aureus subsp. aureus RN4220 RN4220 | GCA_018732165 | complete | ncbi | 561307 |
66792 | Staphylococcus aureus subsp. aureus RN4220 | GCA_011751615 | scaffold | ncbi | 561307 |
66792 | Staphylococcus aureus subsp. aureus RN4220 | GCA_000212435 | contig | ncbi | 561307 |
66792 | Staphylococcus aureus subsp. aureus RN4220 | 561307.24 | complete | patric | 561307 |
66792 | Staphylococcus aureus subsp. aureus RN4220 | 561307.22 | wgs | patric | 561307 |
66792 | Staphylococcus aureus subsp. aureus RN4220 | 561307.5 | wgs | patric | 561307 |
66792 | Staphylococcus aureus subsp. aureus RN4220 | GCA_024296825 | complete | ncbi | 561307 |
Genome-based predictions
predictions
trait | prediction | confidence | training_data |
---|---|---|---|
flagellated | no | 92.128 | no |
gram-positive | yes | 88.988 | no |
anaerobic | no | 99.508 | no |
aerobic | yes | 89.085 | no |
halophile | yes | 94.5 | no |
spore-forming | no | 93.424 | no |
thermophile | no | 99.688 | no |
motile | no | 90.356 | no |
glucose-util | yes | 87.555 | no |
glucose-ferment | yes | 86.048 | no |
External links
@ref: 18922
culture collection no.: DSM 26309
straininfo link
- @ref: 87514
- straininfo: 405493
literature
topic | Pubmed-ID | title | authors | journal | DOI | year | mesh | topic2 |
---|---|---|---|---|---|---|---|---|
Metabolism | 2233255 | Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. | Ross JI, Eady EA, Cove JH, Cunliffe WJ, Baumberg S, Wootton JC | Mol Microbiol | 10.1111/j.1365-2958.1990.tb00696.x | 1990 | Adenosine Triphosphate/*metabolism, Amino Acid Sequence, Bacterial Proteins/*genetics/metabolism, Base Sequence, Biological Transport, Drug Resistance, Microbial/genetics, Erythromycin/*pharmacology, Gene Expression Regulation, Bacterial, *Membrane Transport Proteins, Molecular Sequence Data, *Multigene Family, Restriction Mapping, Sequence Homology, Nucleic Acid, Staphylococcus epidermidis/drug effects/*genetics | Genetics |
Enzymology | 2559912 | Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. | Ross JI, Farrell AM, Eady EA, Cove JH, Cunliffe WJ | J Antimicrob Chemother | 10.1093/jac/24.6.851 | 1989 | Cloning, Molecular, DNA Restriction Enzymes, DNA, Bacterial/analysis/*genetics/isolation & purification, Drug Resistance, Microbial, Microbial Sensitivity Tests, Phenotype, Plasmids, Staphylococcus aureus/drug effects/genetics, Staphylococcus epidermidis/drug effects/*genetics, Transformation, Bacterial, Virginiamycin/*pharmacology | Phenotype |
Enzymology | 3009410 | Cloning and expression of the exfoliative toxin B gene from Staphylococcus aureus. | Jackson MP, Iandolo JJ | J Bacteriol | 10.1128/jb.166.2.574-580.1986 | 1986 | Bacterial Toxins/*genetics, Cadmium/pharmacology, *Cloning, Molecular, DNA Restriction Enzymes/metabolism, Drug Resistance, Microbial, Electrophoresis, Agar Gel, Exfoliatins/*genetics, *Gene Expression Regulation, Immunosorbent Techniques, Staphylococcus aureus/*genetics | Pathogenicity |
Enzymology | 6411618 | Expression of a cloned Staphylococcus aureus alpha-hemolysin determinant in Bacillus subtilis and Staphylococcus aureus. | Fairweather N, Kennedy S, Foster TJ, Kehoe M, Dougan G | Infect Immun | 10.1128/iai.41.3.1112-1117.1983 | 1983 | Bacillus subtilis/*genetics, *Cloning, Molecular, DNA, Bacterial/genetics, *Gene Expression Regulation, *Hemolysin Factors, Hemolytic Plaque Technique, *Plasmids, Staphylococcus aureus/*genetics, Transformation, Bacterial | |
Enzymology | 7492103 | Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. | Ferrero L, Cameron B, Crouzet J | Antimicrob Agents Chemother | 10.1128/AAC.39.7.1554 | 1995 | Ciprofloxacin/*pharmacology, DNA Gyrase, DNA Topoisomerase IV, DNA Topoisomerases, Type II/*genetics, Drug Resistance, Microbial/genetics, Genes, Bacterial, Mutation, Norfloxacin/pharmacokinetics, Staphylococcus aureus/*drug effects/*genetics/metabolism | Pathogenicity |
Metabolism | 7747966 | The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus. | DeHart HP, Heath HE, Heath LS, LeBlanc PA, Sloan GL | Appl Environ Microbiol | 10.1128/aem.61.4.1475-1479.1995 | 1995 | Cell Wall/chemistry/metabolism, Cloning, Molecular, Drug Resistance, Microbial/genetics, Genes, Bacterial, Glycine/analysis, Lysostaphin/metabolism/*pharmacology, Peptidoglycan/chemistry/*metabolism, Serine/analysis, Staphylococcus/drug effects/genetics/*metabolism, Staphylococcus aureus/drug effects/genetics/*metabolism | Enzymology |
Enzymology | 8088537 | A genetic and molecular characterization of the recA gene from Staphylococcus aureus. | Bayles KW, Brunskill EW, Iandolo JJ, Hruska LL, Huang S, Pattee PA, Smiley BK, Yasbin RE | Gene | 10.1016/0378-1119(94)90033-7 | 1994 | Amino Acid Sequence, Base Sequence, Cloning, Molecular, *Genes, Bacterial, Molecular Sequence Data, Mutagenesis, Insertional, Rec A Recombinases/*genetics, Restriction Mapping, Staphylococcus aureus/*genetics | Genetics |
Pathogenicity | 8171126 | Molecular characterization of a plasmid-borne (pGT633) erythromycin resistance determinant (ermGT) from Lactobacillus reuteri 100-63. | Tannock GW, Luchansky JB, Miller L, Connell H, Thode-Andersen S, Mercer AA, Klaenhammer TR | Plasmid | 10.1006/plas.1994.1007 | 1994 | Amino Acid Sequence, Bacillus subtilis/drug effects/genetics, *Bacterial Proteins, Base Sequence, Drug Resistance, Microbial/*genetics, Enterococcus faecalis/drug effects/genetics, Erythromycin/*toxicity, Genes, Bacterial, Lactobacillus/drug effects/*genetics, Methyltransferases/*biosynthesis, Molecular Sequence Data, Nucleic Acid Conformation, Open Reading Frames, *Plasmids, Protein Sorting Signals/genetics, RNA, Messenger/biosynthesis/chemistry, Restriction Mapping, Staphylococcus aureus/drug effects/genetics, Streptococcus sanguis/drug effects/genetics, *Transformation, Bacterial | Genetics |
Genetics | 8335347 | Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins. | Harris TO, Grossman D, Kappler JW, Marrack P, Rich RR, Betley MJ | Infect Immun | 10.1128/iai.61.8.3175-3183.1993 | 1993 | Amino Acid Sequence, Animals, Base Sequence, Enterotoxins/chemistry/immunology/*toxicity, Female, *Lymphocyte Activation, Macaca mulatta, Mice, Mice, Inbred BALB C, Molecular Sequence Data, Mutation, Staphylococcus aureus/*pathogenicity, Structure-Activity Relationship, T-Lymphocytes/*immunology, Vomiting/*chemically induced | Pathogenicity |
Pathogenicity | 8432600 | Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. | Bonventre PF, Heeg H, Cullen C, Lian CJ | Infect Immun | 10.1128/iai.61.3.793-799.1993 | 1993 | Animals, Antibodies, Monoclonal, *Bacterial Toxins, Blood Chemical Analysis, Enterotoxins/immunology/*toxicity, Mitogens, Rabbits, Recombinant Proteins/toxicity, Shock, Septic/*physiopathology, Staphylococcus aureus/*pathogenicity, Structure-Activity Relationship, *Superantigens | |
Phenotype | 8515230 | Recombination at the coagulase locus in Staphylococcus aureus: plasmid integration and amplification. | McDevitt D, Wann ER, Foster TJ | J Gen Microbiol | 10.1099/00221287-139-4-695 | 1993 | Alleles, Blotting, Southern, Coagulase/*genetics, Gene Amplification, Genes, Bacterial, Mutagenesis, Phenotype, *Plasmids, Recombination, Genetic, Staphylococcus aureus/*enzymology/*genetics, Transduction, Genetic, Transformation, Genetic | Enzymology |
Genetics | 8723458 | Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus. | Yamagishi J, Kojima T, Oyamada Y, Fujimoto K, Hattori H, Nakamura S, Inoue M | Antimicrob Agents Chemother | 10.1128/AAC.40.5.1157 | 1996 | Amino Acid Sequence, Base Sequence, DNA Topoisomerase IV, DNA Topoisomerases, Type II/analysis/*genetics, Drug Resistance, Microbial/genetics, Genes, Bacterial/*genetics, Molecular Sequence Data, Mutagenesis, Site-Directed, Mutation, Open Reading Frames, Plasmids/genetics, Quinolones/*chemistry, Sequence Analysis, DNA, Staphylococcus aureus/drug effects/enzymology/*genetics | Transcriptome |
Enzymology | 8795206 | Purification and partial characterization of a novel antibacterial agent (Bac1829) Produced by Staphylococcus aureus KSI1829. | Crupper SS, Iandolo JJ | Appl Environ Microbiol | 10.1128/aem.62.9.3171-3175.1996 | 1996 | Bacteria/*drug effects, Bacteriocins/*isolation & purification/metabolism/pharmacology, Dose-Response Relationship, Drug, Staphylococcus aureus/*metabolism | Metabolism |
Phenotype | 8869496 | Suppression of the thermosensitive replication phenotype of the derivative plasmid of pI9789::Tn552 in Staphylococcus aureus may involve integration of the plasmid into the host chromosome. | Sohail M, Dyke KG | FEMS Microbiol Lett | 10.1111/j.1574-6968.1996.tb08038.x | 1996 | Arsenates/antagonists & inhibitors, Blotting, Southern, Cadmium/antagonists & inhibitors, Chromosomes, Bacterial/genetics, Gene Deletion, Herbicides/antagonists & inhibitors, Lysogeny/*genetics, Mercury/antagonists & inhibitors, Penicillins/antagonists & inhibitors, Phenotype, Plasmids/*genetics, R Factors/genetics, Replicon/genetics, Restriction Mapping, Staphylococcus aureus/*genetics, Temperature | Pathogenicity |
Phenotype | 8996099 | Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. | Ross JI, Eady EA, Cove JH, Baumberg S | Gene | 10.1016/s0378-1119(96)00541-0 | 1996 | Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/*genetics/physiology, Carrier Proteins/genetics/physiology, Chromosomes, Bacterial/genetics, Crossing Over, Genetic, Drug Resistance, Microbial/genetics, Erythromycin/*pharmacology, Gene Expression Regulation, Bacterial/*genetics, Membrane Proteins/genetics/physiology, *Membrane Transport Proteins, Phenotype, Sequence Deletion, Staphylococcus aureus/*drug effects/genetics, Virginiamycin/pharmacology | Pathogenicity |
Enzymology | 9116505 | Purification of Staphylococcus aureus beta-toxin: comparison of three isoelectric focusing methods. | Gaskin DK, Bohach GA, Schlievert PM, Hovde CJ | Protein Expr Purif | 10.1006/prep.1996.0664 | 1997 | Bacterial Toxins/*isolation & purification, Electrophoresis, Polyacrylamide Gel, Hemolysin Proteins, Immunoblotting, Isoelectric Focusing/*methods, Sphingomyelin Phosphodiesterase/*isolation & purification, Staphylococcus aureus/*chemistry | Phylogeny |
Pathogenicity | 9333072 | Quinolone susceptibility of norA-disrupted Staphylococcus aureus. | Yamada H, Kurose-Hamada S, Fukuda Y, Mitsuyama J, Takahata M, Minami S, Watanabe Y, Narita H | Antimicrob Agents Chemother | 10.1128/AAC.41.10.2308 | 1997 | 4-Quinolones, Anti-Infective Agents/chemistry/*pharmacology, Blotting, Southern, Drug Resistance, Microbial, Genes, Bacterial/genetics/*physiology, Microbial Sensitivity Tests, Mutation, Staphylococcus aureus/*drug effects/*genetics | |
Enzymology | 9361432 | Recombinant luminescent bacteria for measuring bioavailable arsenite and antimonite. | Tauriainen S, Karp M, Chang W, Virta M | Appl Environ Microbiol | 10.1128/aem.63.11.4456-4461.1997 | 1997 | Antimony/*pharmacokinetics/toxicity, Arsenites/*pharmacokinetics/toxicity, Bacteria/*metabolism, Biological Availability, DNA, Recombinant, *Luminescent Measurements, Plasmids | Metabolism |
Enzymology | 9573165 | Penicillin-binding protein 1 of Staphylococcus aureus is essential for growth. | Wada A, Watanabe H | J Bacteriol | 10.1128/JB.180.10.2759-2765.1998 | 1998 | Amino Acid Sequence, *Bacterial Proteins, Base Sequence, Carrier Proteins/*genetics/physiology, Cloning, Molecular, *Hexosyltransferases, Molecular Sequence Data, Muramoylpentapeptide Carboxypeptidase/*genetics/physiology, Penicillin-Binding Proteins, *Peptidyl Transferases, Sequence Alignment, Sequence Homology, Amino Acid, Staphylococcus aureus/genetics/*growth & development | Genetics |
Pathogenicity | 9624482 | A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. | Rosato A, Vicarini H, Bonnefoy A, Chantot JF, Leclercq R | Antimicrob Agents Chemother | 10.1128/AAC.42.6.1392 | 1998 | Anti-Bacterial Agents/*pharmacology, Artificial Gene Fusion, Base Sequence, DNA, Bacterial/*drug effects/genetics, Drug Resistance, Microbial, Enterococcus/drug effects/genetics, Erythromycin/pharmacology, *Ketolides, *Macrolides, Molecular Sequence Data, Sequence Alignment, Streptococcus/*drug effects/genetics | Genetics |
Enzymology | 9687416 | Effects of mutations in GrlA of topoisomerase IV from Staphylococcus aureus on quinolone and coumarin activity. | Fournier B, Hooper DC | Antimicrob Agents Chemother | 10.1128/AAC.42.8.2109 | 1998 | Alleles, Anti-Infective Agents/*pharmacology, Coumarins/*pharmacology, DNA Topoisomerase IV, DNA Topoisomerases, Type II/*genetics, Drug Resistance, Microbial, Fluoroquinolones, *Mutation, Staphylococcus aureus/drug effects/*enzymology | Pathogenicity |
Pathogenicity | 9839381 | Luminescent bacterial sensor for cadmium and lead. | Tauriainen S, Karp M, Chang W, Virta M | Biosens Bioelectron | 10.1016/s0956-5663(98)00027-x | 1998 | Animals, Bacillus subtilis/drug effects/enzymology/genetics, Base Sequence, Biosensing Techniques/*methods, Cadmium/*analysis/pharmacology, Coleoptera/enzymology/genetics, DNA Primers/genetics, Freeze Drying, Gene Expression Regulation, Enzymologic/drug effects, Genes, Reporter/drug effects, Lead/*analysis/pharmacology, Luciferases/genetics, Luminescent Measurements, Plasmids/genetics, Staphylococcus aureus/drug effects/genetics | Enzymology |
Genetics | 9919657 | Genetic analysis of the cap5 locus of Staphylococcus aureus. | Wann ER, Dassy B, Fournier JM, Foster TJ | FEMS Microbiol Lett | 10.1111/j.1574-6968.1999.tb13360.x | 1999 | Bacterial Capsules/biosynthesis/chemistry/*genetics, Bacterial Proteins/*genetics, Blotting, Southern, Carbohydrate Sequence, DNA Transposable Elements, DNA, Bacterial, Genetic Complementation Test, Molecular Sequence Data, Mutation, Restriction Mapping, Serotyping, Staphylococcus aureus/classification/*genetics, Transduction, Genetic | Phylogeny |
Enzymology | 10428901 | Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus. | Gootz TD, Zaniewski RP, Haskell SL, Kaczmarek FS, Maurice AE | Antimicrob Agents Chemother | 10.1128/AAC.43.8.1845 | 1999 | Adrenergic Uptake Inhibitors/pharmacology, Anti-Infective Agents/*pharmacology, Antitubercular Agents/pharmacology, Ciprofloxacin/pharmacology, DNA Gyrase, DNA Topoisomerase IV, DNA Topoisomerases, Type II/*genetics/isolation & purification/metabolism, DNA, Bacterial/biosynthesis/metabolism, DNA, Superhelical/metabolism, Drug Interactions, Drug Resistance, Microbial, Enzyme Inhibitors/*pharmacology, *Fluoroquinolones, Levofloxacin, Microbial Sensitivity Tests, Mutation, Naphthyridines/*pharmacology, Ofloxacin/pharmacology, Reserpine/pharmacology, Staphylococcus aureus/*drug effects/*enzymology/genetics/isolation & purification, *Topoisomerase II Inhibitors | Metabolism |
Enzymology | 10436926 | Transposition of IS1181 in the genomes of Staphylococcus and Listeria. | Chesneau O, Lailler R, Derbise A, El Solh N | FEMS Microbiol Lett | 10.1111/j.1574-6968.1999.tb13718.x | 1999 | Base Sequence, Cloning, Molecular/methods, *DNA Transposable Elements, DNA, Bacterial/chemistry/genetics, Genetic Vectors, *Genome, Bacterial, Listeria monocytogenes/*genetics, Mutagenesis, Insertional/*methods, Plasmids, Restriction Mapping, Staphylococcus/*genetics, Staphylococcus aureus/*genetics | Genetics |
Pathogenicity | 10543753 | Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium. | Bozdogan B, Leclercq R | Antimicrob Agents Chemother | 10.1128/AAC.43.11.2720 | 1999 | Acetyltransferases/genetics, Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/genetics, Drug Resistance, Microbial, Enterococcus faecium/*drug effects/*genetics, Genes, Bacterial/*genetics, Genotype, Gram-Positive Bacterial Infections/microbiology, Hemeproteins/genetics, Humans, Methyltransferases/genetics, Microbial Sensitivity Tests, Plasmids/genetics, Polymerase Chain Reaction, Staphylococcus aureus/drug effects, Virginiamycin/*pharmacology | Genetics |
Genetics | 10873532 | A method for demonstrating gene essentiality in Staphylococcus aureus. | Jana M, Luong TT, Komatsuzawa H, Shigeta M, Lee CY | Plasmid | 10.1006/plas.2000.1473 | 2000 | Base Sequence, Genes, Bacterial, Genes, Essential, Molecular Sequence Data, Peptide Synthases/*genetics, Staphylococcus aureus/enzymology/*genetics/growth & development | Enzymology |
Metabolism | 11344159 | Biosynthesis of the glycolipid anchor in lipoteichoic acid of Staphylococcus aureus RN4220: role of YpfP, the diglucosyldiacylglycerol synthase. | Kiriukhin MY, Debabov DV, Shinabarger DL, Neuhaus FC | J Bacteriol | 10.1128/JB.183.11.3506-3514.2001 | 2001 | Animals, Bacterial Proteins/genetics/*metabolism, Escherichia coli/enzymology/genetics, Glucose/metabolism, Glucosyltransferases/genetics/*metabolism, Glycolipids/*metabolism, *Glycosyltransferases, Lipopolysaccharides/*metabolism, Mice, Microscopy, Electron, Scanning, Mutation, Staphylococcal Infections/microbiology, Staphylococcus aureus/*enzymology/genetics/growth & development/pathogenicity, Teichoic Acids/*metabolism, Virulence | Enzymology |
Pathogenicity | 11368915 | Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. | Narita S, Kaneko J, Chiba J, Piemont Y, Jarraud S, Etienne J, Kamio Y | Gene | 10.1016/s0378-1119(01)00390-0 | 2001 | Amino Acid Sequence, *Bacterial Proteins, Bacterial Toxins, Base Sequence, Capsid/biosynthesis/genetics, Exotoxins, *Gene Conversion, *Genome, Viral, Humans, Leukocidins/*genetics, Lysogeny/physiology, Membrane Proteins/genetics, Molecular Sequence Data, Operon, Promoter Regions, Genetic, Sequence Analysis, DNA, Sequence Homology, Amino Acid, Staphylococcus Phages/*genetics/isolation & purification, Staphylococcus aureus/genetics/pathogenicity/*virology, Terminator Regions, Genetic, Viral Proteins/analysis, Virus Replication | Genetics |
Metabolism | 11535794 | The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen. | Hartford O, O'Brien L, Schofield K, Wells J, Foster TJ | Microbiology (Reading) | 10.1099/00221287-147-9-2545 | 2001 | Adhesins, Bacterial/genetics/physiology, Bacterial Adhesion/genetics/physiology, Bacterial Proteins/genetics/*physiology, Base Sequence, Carrier Proteins/genetics/*physiology, DNA Transposable Elements/genetics, DNA, Bacterial/genetics, Fibrinogen/*metabolism, Gene Expression, Genes, Bacterial, Mutation, Plasmids/genetics, Staphylococcus epidermidis/genetics/*physiology | |
Metabolism | 11673420 | Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus. | Pinho MG, Filipe SR, de Lencastre H, Tomasz A | J Bacteriol | 10.1128/JB.183.22.6525-6531.2001 | 2001 | Aminoacyltransferases/*metabolism, *Bacterial Proteins, Carrier Proteins/genetics/*metabolism, Drug Resistance, Bacterial, *Hexosyltransferases, Methicillin/pharmacology, Muramoylpentapeptide Carboxypeptidase/deficiency/genetics/*metabolism, Penicillin-Binding Proteins, Penicillins/pharmacology, *Peptidyl Transferases, Staphylococcus aureus/drug effects/genetics/*metabolism, Transcription, Genetic | Pathogenicity |
Cultivation | 11709324 | Measurement of effects of antibiotics in bioluminescent Staphylococcus aureus RN4220. | Tenhami M, Hakkila K, Karp M | Antimicrob Agents Chemother | 10.1128/AAC.45.12.3456-3461.2001 | 2001 | Anti-Bacterial Agents/*pharmacology, Culture Media, Drug Evaluation, Preclinical, Hydrogen-Ion Concentration, Luminescent Measurements, Microbial Sensitivity Tests/*methods, Photometry, Staphylococcus aureus/*drug effects | Pathogenicity |
Metabolism | 11751840 | Direct quantitation of the numbers of individual penicillin-binding proteins per cell in Staphylococcus aureus. | Pucci MJ, Dougherty TJ | J Bacteriol | 10.1128/JB.184.2.588-591.2002 | 2002 | *Bacterial Proteins, Carrier Proteins/*metabolism, Densitometry/methods, *Hexosyltransferases, Isotope Labeling, Lasers, *Methicillin Resistance, Muramoylpentapeptide Carboxypeptidase/*metabolism, Penicillin G/*metabolism, Penicillin-Binding Proteins, *Peptidyl Transferases, Staphylococcus aureus/growth & development/*metabolism, Tritium | |
Cultivation | 11822776 | Genetic linkage between resistance to quaternary ammonium compounds and beta-lactam antibiotics in food-related Staphylococcus spp. | Sidhu MS, Heir E, Sorum H, Holck A | Microb Drug Resist | 10.1089/10766290152773374 | 2001 | Anti-Bacterial Agents/*pharmacology, Anti-Infective Agents, Local/pharmacology, Benzalkonium Compounds/pharmacology, Blotting, Southern, Culture Media, DNA, Bacterial/genetics/isolation & purification, Drug Resistance, Microbial, *Food Microbiology, Hybridization, Genetic, Microbial Sensitivity Tests, Plasmids/genetics, Quaternary Ammonium Compounds/*pharmacology, Reverse Transcriptase Polymerase Chain Reaction, Staphylococcus/*drug effects/*growth & development, Transformation, Bacterial/genetics, beta-Lactam Resistance/*genetics, beta-Lactams | Biotechnology |
Pathogenicity | 12069975 | Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus. | Malbruny B, Canu A, Bozdogan B, Fantin B, Zarrouk V, Dutka-Malen S, Feger C, Leclercq R | Antimicrob Agents Chemother | 10.1128/AAC.46.7.2200-2207.2002 | 2002 | Amino Acid Sequence, Bacterial Proteins/*genetics, Drug Resistance, Microbial/*genetics, Drug Therapy, Combination/*pharmacology, Humans, Molecular Sequence Data, *Mutation, RNA, Ribosomal, 23S/genetics, RNA-Binding Proteins/chemistry/*genetics, *Ribosomal Proteins, Ribosomes/metabolism, Staphylococcus aureus/*drug effects/genetics, Virginiamycin/*pharmacology | Genetics |
Metabolism | 12121924 | Small-colony mutants of Staphylococcus aureus allow selection of gyrase-mediated resistance to dual-target fluoroquinolones. | Pan XS, Hamlyn PJ, Talens-Visconti R, Alovero FL, Manzo RH, Fisher LM | Antimicrob Agents Chemother | 10.1128/AAC.46.8.2498-2506.2002 | 2002 | Anti-Infective Agents/*pharmacology, Coagulase/metabolism, DNA Gyrase/biosynthesis/genetics/*metabolism, DNA Topoisomerase IV/genetics/metabolism, Drug Resistance, Microbial, *Fluoroquinolones, Hemin/metabolism, Microbial Sensitivity Tests, Mutation/*genetics, Phenotype, Quinolones/pharmacology, Staphylococcus aureus/enzymology/*genetics, Thymidine/metabolism, Vitamin K 3/metabolism | Phenotype |
Pathogenicity | 12161395 | Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low. | O'Neill AJ, Chopra I | J Antimicrob Chemother | 10.1093/jac/dkf118 | 2002 | Adenosine Triphosphatases/*genetics, *Bacterial Proteins, *DNA-Binding Proteins, Escherichia coli Proteins/*genetics, Humans, MutS DNA Mismatch-Binding Protein, *Mutagenesis, Insertional/methods, Mutation/*genetics, Sequence Analysis, DNA/methods, Staphylococcus aureus/*genetics/*isolation & purification | Transcriptome |
Pathogenicity | 12384362 | An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. | Schaaff F, Reipert A, Bierbaum G | Antimicrob Agents Chemother | 10.1128/AAC.46.11.3540-3548.2002 | 2002 | Adenosine Triphosphatases/genetics, Anti-Bacterial Agents/pharmacology, Antibiotics, Antitubercular/pharmacology, *Bacterial Proteins, Bacteriophage Typing, *DNA-Binding Proteins, Drug Resistance, Microbial, Escherichia coli Proteins/genetics, Genetic Complementation Test, Microbial Sensitivity Tests, MutS DNA Mismatch-Binding Protein, Mutation/*genetics, Rifampin/pharmacology, Staphylococcus aureus/drug effects/*genetics/growth & development, Teicoplanin/pharmacology, Vancomycin Resistance/*genetics | |
Pathogenicity | 12443831 | Characterization of a holin (HolNU3-1) in methicillin-resistant Staphylococcus aureus host. | Horii T, Suzuki Y, Kobayashi M | FEMS Immunol Med Microbiol | 10.1111/j.1574-695X.2002.tb00638.x | 2002 | Amino Acid Sequence, Bacterial Proteins/chemistry/*genetics/*metabolism, Bacteriophages, Cloning, Molecular, Evolution, Molecular, Humans, *Methicillin Resistance, Molecular Sequence Data, *N-Acetylmuramoyl-L-alanine Amidase, Sequence Analysis, DNA, Sequence Homology, Amino Acid, Staphylococcal Infections/microbiology, Staphylococcus aureus/*drug effects/genetics/metabolism | Metabolism |
Pathogenicity | 12519196 | Molecular analysis of fusidic acid resistance in Staphylococcus aureus. | Besier S, Ludwig A, Brade V, Wichelhaus TA | Mol Microbiol | 10.1046/j.1365-2958.2003.03307.x | 2003 | Amino Acid Sequence, *Amino Acid Substitution, Anti-Bacterial Agents/*pharmacology, Cloning, Molecular, Drug Resistance, Bacterial/*genetics, Fusidic Acid/*pharmacology, Humans, Microbial Sensitivity Tests, Molecular Sequence Data, Mutagenesis, Site-Directed, Peptide Elongation Factor G/chemistry/genetics, Point Mutation, Reverse Transcriptase Polymerase Chain Reaction, Staphylococcus aureus/*drug effects/genetics | Enzymology |
Pathogenicity | 12677529 | Biflavonoids with cytotoxic and antibacterial activity from Ochna macrocalyx. | Tang S, Bremner P, Kortenkamp A, Schlage C, Gray AI, Gibbons S, Heinrich M | Planta Med | 10.1055/s-2003-38478 | 2003 | Anti-Bacterial Agents/*pharmacology, Antineoplastic Agents, Phytogenic/*pharmacology, Breast Neoplasms/drug therapy/pathology, Drug Resistance, Multiple, Flavonoids/chemistry/*pharmacology, Humans, Magnetic Resonance Spectroscopy, *Malpighiaceae, Microbial Sensitivity Tests, NF-kappa B/antagonists & inhibitors, *Phytotherapy, Plant Bark, Plant Extracts/chemistry/*pharmacology, Staphylococcus aureus/drug effects, Tumor Cells, Cultured/drug effects | |
Pathogenicity | 12726988 | Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus. | Ruzin A, Severin A, Moghazeh SL, Etienne J, Bradford PA, Projan SJ, Shlaes DM | Biochim Biophys Acta | 10.1016/s0304-4165(03)00028-x | 2003 | Aminoacyltransferases, Bacterial Proteins/*genetics/physiology, DNA Transposable Elements, Microbial Sensitivity Tests, Mutagenesis, Insertional, Staphylococcus aureus/*drug effects, Vancomycin Resistance/*genetics | |
15000739 | Effect of disruption of Staphylococcus aureus PBP4 gene on resistance to beta-lactam antibiotics. | Katayama Y, Zhang HZ, Chambers HF | Microb Drug Resist | 10.1089/107662903322762752 | 2003 | Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/*genetics, Carrier Proteins/*genetics, DNA, Bacterial/genetics, Electroporation, Genes, Bacterial/genetics, Genetic Complementation Test, Hexosyltransferases/*genetics, Muramoylpentapeptide Carboxypeptidase/*genetics, Mutagenesis, Nafcillin/pharmacology, Penicillin-Binding Proteins, Penicillins/pharmacology, Peptidyl Transferases/*genetics, Plasmids/genetics, Reverse Transcriptase Polymerase Chain Reaction, Staphylococcus aureus/*genetics/growth & development, beta-Lactam Resistance/*genetics | ||
Metabolism | 15073314 | Low-proline environments impair growth, proline transport and in vivo survival of Staphylococcus aureus strain-specific putP mutants. | Schwan WR, Wetzel KJ, Gomez TS, Stiles MA, Beitlich BD, Grunwald S | Microbiology (Reading) | 10.1099/mic.0.26710-0 | 2004 | Amino Acid Transport Systems, Neutral/*genetics/metabolism, Animals, Culture Media, Escherichia coli/genetics/metabolism, Humans, Lethal Dose 50, Mice, Mice, Inbred BALB C, *Mutation, Plasmids, Proline/*metabolism, Species Specificity, Staphylococcal Infections/microbiology/physiopathology, Staphylococcus aureus/classification/genetics/*growth & development/*pathogenicity, Virulence | Phylogeny |
Pathogenicity | 15287009 | Discarding multidrug resistance inducers, the possible role of a biosensing reporter in antimicrobial discovery. | Galluzzi L, Virtanen P, Karp M | Luminescence | 10.1002/bio.771 | 2004 | Biosensing Techniques, Disinfectants/*pharmacology, Dose-Response Relationship, Drug, Drug Resistance, Microbial/*genetics, Drug Resistance, Multiple/*genetics, Genes, Reporter, Plasmids, Staphylococcus aureus/*drug effects/*genetics | |
Pathogenicity | 15336408 | The cme gene of Clostridium difficile confers multidrug resistance in Enterococcus faecalis. | Lebel S, Bouttier S, Lambert T | FEMS Microbiol Lett | 10.1016/j.femsle.2004.07.022 | 2004 | Amino Acid Sequence, Anti-Bacterial Agents/metabolism/*pharmacology, Bacterial Proteins/chemistry/genetics/metabolism, Biological Transport, Active, Cloning, Molecular, Clostridioides difficile/*genetics, Consensus Sequence, DNA, Bacterial/chemistry/genetics/isolation & purification, Drug Resistance, Multiple, Bacterial/*genetics, Enterococcus faecalis/*drug effects/genetics, Erythromycin/pharmacology, Ethidium/pharmacology, Gene Expression, *Genes, Bacterial, Molecular Sequence Data, Multidrug Resistance-Associated Proteins, *Open Reading Frames, Phenazines/pharmacology, Recombinant Proteins/metabolism, Sequence Alignment, Sequence Analysis, DNA, Sequence Homology, Staphylococcus aureus/drug effects/genetics | Metabolism |
Pathogenicity | 15471995 | Nucleotide sequence and organization of the multiresistance plasmid pSCFS1 from Staphylococcus sciuri. | Kehrenberg C, Ojo KK, Schwarz S | J Antimicrob Chemother | 10.1093/jac/dkh457 | 2004 | ATP-Binding Cassette Transporters/genetics/physiology, Base Sequence, Drug Resistance, Multiple, Bacterial/*genetics, Open Reading Frames, *Plasmids, Staphylococcus/*drug effects/*genetics | |
Metabolism | 15477462 | Intravitreally injected human immunoglobulin attenuates the effects of Staphylococcus aureus culture supernatant in a rabbit model of toxin-mediated endophthalmitis. | Perkins SL, Han DP, Burke JM, Schlievert PM, Wirostko WJ, Tarasewicz DG, Skumatz CM | Arch Ophthalmol | 10.1001/archopht.122.10.1499 | 2004 | Animals, Bacterial Toxins/immunology/metabolism/*pharmacology, Culture Media/metabolism, Disease Models, Animal, Endophthalmitis/*immunology/pathology/*therapy, Enterotoxins/immunology/metabolism/pharmacology, Hemolysin Proteins, Humans, Immunoglobulins/*pharmacology, Immunotherapy/methods, Rabbits, Retina/immunology/pathology, Sphingomyelin Phosphodiesterase/immunology/metabolism/*pharmacology, *Staphylococcus aureus/metabolism, Superantigens/immunology/metabolism/pharmacology, Vitreous Body/immunology/pathology | Pathogenicity |
Phenotype | 15519475 | Bactericidal activity of quinupristin-dalfopristin against strains of Staphylococcus aureus with the MLS(B) phenotype of resistance according to the erm gene type. | Clarebout G, Nativelle E, Bozdogan B, Villers C, Leclercq R | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2004.06.016 | 2004 | Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/genetics, Drug Resistance, Bacterial/*genetics, Genes, Bacterial/genetics, Genotype, Methyltransferases/genetics, Microbial Sensitivity Tests/methods, Phenotype, Staphylococcus aureus/*drug effects/*enzymology, Virginiamycin/*pharmacology | Genetics |
Pathogenicity | 15531595 | Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus. | O'Neill AJ, Miller K, Oliva B, Chopra I | J Antimicrob Chemother | 10.1093/jac/dkh476 | 2004 | Anti-Bacterial Agents/*pharmacology, Bacteriolysis, Cell Membrane/*drug effects, Cell Membrane Permeability/drug effects, Cetrimonium, Cetrimonium Compounds/pharmacology, Microbial Sensitivity Tests, Nisin/pharmacology, Protoplasts/drug effects, Staphylococcus aureus/*drug effects/enzymology/genetics, beta-Galactosidase/genetics/metabolism | Enzymology |
Pathogenicity | 15638329 | Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance. | Ishino K, Ishikawa J, Ikeda Y, Hotta K | J Antibiot (Tokyo) | 10.7164/antibiotics.57.679 | 2004 | Amino Acid Sequence, Aminoglycosides/*metabolism/*pharmacology, Dibekacin/*analogs & derivatives/*pharmacology, Drug Resistance, Bacterial, Humans, *Methicillin Resistance, Molecular Sequence Data, Phosphorylation, RNA, Messenger/analysis, Staphylococcus aureus/drug effects/*enzymology/genetics, Substrate Specificity | Enzymology |
Pathogenicity | 15649995 | Enhanced resistance to erythromycin is conferred by the enterococcal msrC determinant in Staphylococcus aureus. | Reynolds E, Cove JH | J Antimicrob Chemother | 10.1093/jac/dkh541 | 2005 | Bacterial Proteins/*genetics/isolation & purification, Base Sequence, Drug Resistance, Bacterial/drug effects/*genetics, Enterococcus faecium/*drug effects/genetics, Erythromycin/*pharmacology, Molecular Sequence Data, Staphylococcus aureus/drug effects/*genetics | Genetics |
Pathogenicity | 15747765 | Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis. | Han DP | Trans Am Ophthalmol Soc | 2004 | Animals, *Bacterial Toxins, Drug Administration Schedule, Endophthalmitis/*chemically induced/metabolism/*pathology, *Exotoxins, Feasibility Studies, Humans, Immunoglobulins/*administration & dosage/metabolism/pharmacology, Injections, Rabbits, *Staphylococcus aureus, *Vitreous Body | Metabolism | |
Enzymology | 15817797 | Sau42I, a BcgI-like restriction-modification system encoded by the Staphylococcus aureus quadruple-converting phage Phi42. | Dempsey RM, Carroll D, Kong H, Higgins L, Keane CT, Coleman DC | Microbiology (Reading) | 10.1099/mic.0.27646-0 | 2005 | Amino Acid Sequence, Chromosome Mapping, Cloning, Molecular, DNA Restriction-Modification Enzymes/*genetics/*metabolism, Escherichia coli/genetics, Genes, Viral, Lysogeny, Molecular Sequence Data, Open Reading Frames, Phenotype, Sequence Homology, Amino Acid, Staphylococcus Phages/classification/*genetics/*metabolism, Staphylococcus aureus/virology | Metabolism |
Enzymology | 15866932 | Role of mutS and mutL genes in hypermutability and recombination in Staphylococcus aureus. | Prunier AL, Leclercq R | J Bacteriol | 10.1128/JB.187.10.3455-3464.2005 | 2005 | Adenosine Triphosphatases/*genetics, Bacterial Proteins/*genetics, Cloning, Molecular, DNA Repair Enzymes/*genetics, DNA-Binding Proteins/*genetics, Escherichia coli Proteins, MutS DNA Mismatch-Binding Protein, Mutation/genetics, Operon/genetics, Phenotype, Recombination, Genetic/*genetics, Staphylococcus aureus/classification/*enzymology/*genetics | Phenotype |
Genetics | 15980097 | Staphylococcal tetracycline-MLSB resistance plasmid pSTE2 is the product of an RSA-mediated in vivo recombination. | Hauschild T, Luthje P, Schwarz S | J Antimicrob Chemother | 10.1093/jac/dki207 | 2005 | Anti-Bacterial Agents/*pharmacology, Base Sequence, Drug Resistance, Multiple, Bacterial/*genetics, Genes, Bacterial, Molecular Sequence Data, Plasmids/*genetics, *Recombination, Genetic, Staphylococcus/drug effects/*genetics, Tetracycline Resistance/*genetics | Pathogenicity |
Pathogenicity | 16468992 | A slipped-mispairing mutation in AgrA of laboratory strains and clinical isolates results in delayed activation of agr and failure to translate delta- and alpha-haemolysins. | Traber K, Novick R | Mol Microbiol | 10.1111/j.1365-2958.2006.04986.x | 2006 | Adenine, Amino Acid Sequence, Bacterial Proteins/*genetics/metabolism, Bacterial Toxins/*genetics/metabolism, Base Sequence, *Frameshift Mutation, Gene Expression Regulation, Bacterial, Genetic Complementation Test, Hemolysin Proteins, Humans, Laboratories, Methylnitronitrosoguanidine/pharmacology, Molecular Sequence Data, Protein Biosynthesis, Staphylococcus aureus/drug effects/*genetics/isolation & purification, Trans-Activators/*genetics/metabolism | Metabolism |
Enzymology | 16644226 | A novel antimicrobial epoxide isolated from larval Galleria mellonella infected by the nematode symbiont, Photorhabdus luminescens (Enterobacteriaceae). | Hu K, Li J, Li B, Webster JM, Chen G | Bioorg Med Chem | 10.1016/j.bmc.2006.01.025 | 2006 | Animals, Anti-Bacterial Agents/*chemistry/isolation & purification/pharmacology, Antibiotics, Antineoplastic/*chemistry/isolation & purification/pharmacology, Bacteria/drug effects, Cell Line, Tumor, Epoxy Compounds/chemistry/isolation & purification/pharmacology, Humans, Larva/chemistry/microbiology, Lepidoptera/*metabolism/*microbiology, Mice, Phenoxypropanolamines/*chemistry/isolation & purification/*pharmacology, *Photorhabdus, Propylamines/*chemistry/isolation & purification/*pharmacology | Phylogeny |
Enzymology | 16855248 | Sau1: a novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. | Waldron DE, Lindsay JA | J Bacteriol | 10.1128/JB.00418-06 | 2006 | Bacterial Proteins/genetics, DNA Restriction-Modification Enzymes/genetics, Deoxyribonucleases, Type I Site-Specific/genetics/*physiology, *Gene Transfer, Horizontal, *Genes, Bacterial, Genetic Variation, Species Specificity, Staphylococcus aureus/drug effects/enzymology/*genetics, Vancomycin Resistance | Phylogeny |
Metabolism | 17198402 | Repression of Staphylococcus aureus SrrAB using inducible antisense srrA alters growth and virulence factor transcript levels. | Pragman AA, Ji Y, Schlievert PM | Biochemistry | 10.1021/bi0603266 | 2007 | Bacterial Proteins/antagonists & inhibitors/genetics/metabolism/*physiology, Down-Regulation, *Gene Expression Regulation, Bacterial, Metabolism, Models, Biological, RNA, Antisense/metabolism, RNA, Bacterial/metabolism, Repressor Proteins/antagonists & inhibitors/genetics/metabolism/*physiology, Reverse Transcriptase Polymerase Chain Reaction, Staphylococcus aureus/genetics/growth & development/*pathogenicity, Time Factors, Transcription, Genetic, Virulence Factors/*genetics/metabolism | |
Enzymology | 17329268 | Identification and characterization of nine novel types of small staphylococcal plasmids carrying the lincosamide nucleotidyltransferase gene lnu(A). | Luthje P, von Kockritz-Blickwede M, Schwarz S | J Antimicrob Chemother | 10.1093/jac/dkm008 | 2007 | Animals, Anti-Bacterial Agents/*pharmacology, Blotting, Southern, Cattle, DNA, Bacterial/genetics, Drug Resistance, Bacterial/genetics, Female, Gene Dosage, Gene Expression Regulation, Bacterial/genetics, Lincosamides, Macrolides/*pharmacology, Mastitis, Bovine/microbiology, Microbial Sensitivity Tests, Nucleotidyltransferases/*genetics, Reverse Transcriptase Polymerase Chain Reaction, Reverse Transcription, Staphylococcus aureus/drug effects/*enzymology/*genetics, Transformation, Bacterial | Pathogenicity |
Pathogenicity | 17462772 | Specific Bifidobacterium strains isolated from elderly subjects inhibit growth of Staphylococcus aureus. | Lahtinen SJ, Jalonen L, Ouwehand AC, Salminen SJ | Int J Food Microbiol | 10.1016/j.ijfoodmicro.2007.02.023 | 2007 | Aged, 80 and over, *Antibiosis/physiology, Bifidobacterium/*physiology, Colony Count, Microbial, Escherichia coli K12/growth & development, Gastrointestinal Tract/*microbiology, Humans, Hydrogen Peroxide/metabolism, Luminescence, Salmonella typhimurium/growth & development, Staphylococcus aureus/*growth & development | Metabolism |
Metabolism | 17620379 | Role of a qnr-like gene in the intrinsic resistance of Enterococcus faecalis to fluoroquinolones. | Arsene S, Leclercq R | Antimicrob Agents Chemother | 10.1128/AAC.00274-07 | 2007 | Amino Acid Sequence, Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/metabolism, Culture Media, DNA Gyrase/metabolism, Drug Resistance, Bacterial/*genetics, Enterococcus faecalis/*drug effects/*genetics, Fluoroquinolones/*pharmacology, Gene Expression Regulation, Bacterial/genetics, *Genes, Bacterial, Microbial Sensitivity Tests, Molecular Sequence Data, Reverse Transcriptase Polymerase Chain Reaction | Cultivation |
Pathogenicity | 17666795 | Transduction of the plasmid encoding antiseptic resistance gene qacB in Staphylococcus aureus. | Nakaminami H, Noguchi N, Nishijima S, Kurokawa I, So H, Sasatsu M | Biol Pharm Bull | 10.1248/bpb.30.1412 | 2007 | Bacterial Proteins/*genetics, Bacteriophage Typing, Blotting, Southern, Conjugation, Genetic, DNA, Bacterial/genetics, Drug Resistance, Bacterial/*genetics, Humans, Membrane Transport Proteins/*genetics, Methicillin Resistance/*genetics, Plasmids/*genetics, Reverse Transcriptase Polymerase Chain Reaction, Staphylococcal Infections/microbiology, Staphylococcus aureus/*genetics, Transduction, Genetic | |
Pathogenicity | 17714489 | Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus. | Daurel C, Prunier AL, Chau F, Garry L, Leclercq R, Fantin B | FEMS Immunol Med Microbiol | 10.1111/j.1574-695X.2007.00310.x | 2007 | Adenosine Triphosphatases/genetics, Animals, Bacterial Proteins/genetics, Bone and Bones/microbiology, Colony Count, Microbial, Drug Resistance, Bacterial/*genetics, Gene Deletion, Microbial Sensitivity Tests, Mutagenesis, Insertional, Osteomyelitis/drug therapy/*microbiology, Rats, Rifampin/therapeutic use, Staphylococcal Infections/drug therapy/*microbiology, Staphylococcus aureus/drug effects/*genetics/*physiology, Survival Analysis | |
Pathogenicity | 18047789 | Detection of antistaphylococcal and toxic compounds by biological assay systems developed with a reporter Staphylococcus aureus strain harboring a heat inducible promoter - lacZ transcriptional fusion. | Chanda PK, Ganguly T, Das M, Lee CY, Luong TT, Sau S | J Biochem Mol Biol | 10.5483/bmbrep.2007.40.6.936 | 2007 | Anti-Bacterial Agents/*pharmacology, Arsenates/pharmacology, Base Sequence, Biological Assay/methods, Chaperonin 10/genetics, Chaperonin 60/genetics, DNA Primers/genetics, Gene Fusion, Genes, Bacterial/drug effects, Genes, Reporter, Hot Temperature, Hydrogen Peroxide/pharmacology, Lac Operon, Microbial Sensitivity Tests/methods, Operon, Promoter Regions, Genetic/drug effects, Staphylococcus aureus/*drug effects/*genetics | Stress |
Transcriptome | 18077631 | Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes. | Daurel C, Huet C, Dhalluin A, Bes M, Etienne J, Leclercq R | J Clin Microbiol | 10.1128/JCM.01925-07 | 2007 | Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/*genetics, Clindamycin/*pharmacology, DNA, Bacterial/genetics, Drug Resistance, Bacterial/*genetics, Macrolides/pharmacology, Methyltransferases/*genetics, *Mutation, *Selection, Genetic, Sequence Analysis, DNA, Staphylococcus aureus/drug effects/*genetics, Streptogramin Group B/pharmacology | Pathogenicity |
Enzymology | 18510563 | Two thermostable nucleases coexisted in Staphylococcus aureus: evidence from mutagenesis and in vitro expression. | Tang J, Zhou R, Shi X, Kang M, Wang H, Chen H | FEMS Microbiol Lett | 10.1111/j.1574-6968.2008.01194.x | 2008 | Bacterial Proteins/*genetics, Cloning, Molecular, DNA, Bacterial/isolation & purification, Enzyme Stability, Escherichia coli/enzymology, Gene Deletion, Gene Expression Regulation, Bacterial, Genes, Bacterial, Micrococcal Nuclease/*genetics, Plasmids, RNA, Bacterial/isolation & purification, Recombinant Proteins/biosynthesis, Reverse Transcriptase Polymerase Chain Reaction, Staphylococcus aureus/*enzymology/*genetics, Transformation, Bacterial | Phylogeny |
Pathogenicity | 18571379 | Frequencies of resistance to Melaleuca alternifolia (tea tree) oil and rifampicin in Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis. | Hammer KA, Carson CF, Riley TV | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2008.03.013 | 2008 | Anti-Bacterial Agents/*pharmacology, *Drug Resistance, Bacterial/genetics, Enterococcus faecalis/drug effects/genetics, Gram-Positive Cocci/*drug effects/genetics, Humans, Melaleuca/chemistry, Microbial Sensitivity Tests, Mutation, Rifampin/*pharmacology, Staphylococcus aureus/drug effects/genetics, Staphylococcus epidermidis/drug effects/genetics, Tea Tree Oil/*pharmacology | |
Pathogenicity | 18638536 | Antibacterial, antioxidant and fibroblast growth stimulation of aqueous extracts of Ficus asperifolia Miq. and Gossypium arboreum L., wound-healing plants of Ghana. | Annan K, Houghton PJ | J Ethnopharmacol | 10.1016/j.jep.2008.06.017 | 2008 | Anti-Bacterial Agents/administration & dosage/isolation & purification/pharmacology, Antioxidants/administration & dosage/isolation & purification/pharmacology, Cell Line, Dose-Response Relationship, Drug, Fibroblasts/drug effects/metabolism, Ficus/*chemistry, Ghana, Gossypium/*chemistry, Humans, Hydrogen Peroxide/toxicity, Medicine, African Traditional, Oxidative Stress/*drug effects, Plant Extracts/administration & dosage/*pharmacology, Plant Leaves, Wound Healing/drug effects | Enzymology |
Metabolism | 18803257 | Antibiotics, arsenate and H2O2 induce the promoter of Staphylococcus aureus cspC gene more strongly than cold. | Chanda PK, Mondal R, Sau K, Sau S | J Basic Microbiol | 10.1002/jobm.200800065 | 2009 | Amino Acid Sequence, Anti-Bacterial Agents/*pharmacology, Arsenates/*pharmacology, Bacterial Proteins/genetics/metabolism, Cloning, Molecular, *Cold Temperature, Gene Expression Regulation, Bacterial, Heat-Shock Proteins/genetics/metabolism, Hydrogen Peroxide/*pharmacology, Molecular Sequence Data, Promoter Regions, Genetic/drug effects, Sequence Alignment, Staphylococcus aureus/drug effects/*genetics/metabolism, beta-Galactosidase/genetics/metabolism | Enzymology |
Enzymology | 19304835 | Inactivation of the SauI type I restriction-modification system is not sufficient to generate Staphylococcus aureus strains capable of efficiently accepting foreign DNA. | Veiga H, Pinho MG | Appl Environ Microbiol | 10.1128/AEM.01862-08 | 2009 | DNA Restriction-Modification Enzymes/*genetics/metabolism, DNA, Bacterial/*metabolism, *Gene Deletion, *Gene Transfer, Horizontal, Staphylococcus aureus/*enzymology/*genetics, *Transformation, Bacterial | Metabolism |
Pathogenicity | 19528208 | Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein. | Shahrooei M, Hira V, Stijlemans B, Merckx R, Hermans PW, Van Eldere J | Infect Immun | 10.1128/IAI.01464-08 | 2009 | Animals, Antibodies, Bacterial/*pharmacology, Bacterial Proteins/immunology/*physiology, *Biofilms, Fibrinogen/metabolism, Humans, Rabbits, Rats, Rats, Inbred F344, Staphylococcus epidermidis/*physiology | Metabolism |
Pathogenicity | 20100878 | Activity of linezolid in an in vitro pharmacokinetic-pharmacodynamic model using different dosages and Staphylococcus aureus and Enterococcus faecalis strains with and without a hypermutator phenotype. | Ba BB, Arpin C, Bikie Bi Nso B, Dubois V, Saux MC, Quentin C | Antimicrob Agents Chemother | 10.1128/AAC.01022-09 | 2010 | Acetamides/administration & dosage/*pharmacokinetics/*pharmacology, Anti-Bacterial Agents/administration & dosage/*pharmacokinetics/*pharmacology, Base Sequence, DNA Primers/genetics, Dose-Response Relationship, Drug, Drug Resistance, Bacterial/genetics, Enterococcus faecalis/*drug effects/*genetics, Humans, In Vitro Techniques, Linezolid, Microbial Sensitivity Tests, Models, Biological, Oxazolidinones/administration & dosage/*pharmacokinetics/*pharmacology, Phenotype, Point Mutation, RNA, Bacterial/genetics, RNA, Ribosomal, 23S/genetics, Species Specificity, Staphylococcus aureus/*drug effects/*genetics | Phenotype |
Metabolism | 20185825 | Glycosylation of wall teichoic acid in Staphylococcus aureus by TarM. | Xia G, Maier L, Sanchez-Carballo P, Li M, Otto M, Holst O, Peschel A | J Biol Chem | 10.1074/jbc.M109.096172 | 2010 | Acetylglucosamine/chemistry/genetics/metabolism, Amino Acid Sequence, Bacterial Proteins/chemistry/genetics/*metabolism, Cell Wall/chemistry/*enzymology/genetics, DNA Transposable Elements/genetics, Gene Knockdown Techniques, Glycosylation, Glycosyltransferases/chemistry/genetics/*metabolism, Magnetic Resonance Spectroscopy, Mutation, Polysaccharides/chemistry/genetics/metabolism, Recombinant Proteins/chemistry/genetics/metabolism, Sequence Deletion, Staphylococcus aureus/*enzymology/genetics, Teichoic Acids/*biosynthesis/chemistry/genetics | Enzymology |
Pathogenicity | 20585119 | Cloning and occurrence of czrC, a gene conferring cadmium and zinc resistance in methicillin-resistant Staphylococcus aureus CC398 isolates. | Cavaco LM, Hasman H, Stegger M, Andersen PS, Skov R, Fluit AC, Ito T, Aarestrup FM | Antimicrob Agents Chemother | 10.1128/AAC.00058-10 | 2010 | Acetates/*pharmacology, Animals, Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/genetics/*physiology, Cadmium/*pharmacology, Chlorides/*pharmacology, Humans, Methicillin Resistance/*genetics, Microbial Sensitivity Tests, Staphylococcus aureus/*drug effects/*genetics, Swine, Zinc Compounds/*pharmacology | Enzymology |
Metabolism | 20937760 | Characterization of a Staphylococcus aureus surface virulence factor that promotes resistance to oxidative killing and infectious endocarditis. | Malachowa N, Kohler PL, Schlievert PM, Chuang ON, Dunny GM, Kobayashi SD, Miedzobrodzki J, Bohach GA, Seo KS | Infect Immun | 10.1128/IAI.00736-10 | 2010 | Animals, Bacterial Proteins/genetics/*metabolism, Computational Biology, Endocarditis, Bacterial/*microbiology, Gene Deletion, Gene Expression Regulation, Bacterial/physiology, Humans, Neutrophils/physiology, Oxidative Stress, Polymorphism, Restriction Fragment Length, Rabbits, Staphylococcus aureus/*metabolism, Virulence Factors/chemistry/genetics/*metabolism | Pathogenicity |
Metabolism | 21049039 | Duckweed (Lemna minor) as a model plant system for the study of human microbial pathogenesis. | Zhang Y, Hu Y, Yang B, Ma F, Lu P, Li L, Wan C, Rayner S, Chen S | PLoS One | 10.1371/journal.pone.0013527 | 2010 | Bacterial Infections/*metabolism/microbiology, Humans, Plants/*metabolism, Pseudomonas aeruginosa/growth & development/isolation & purification, Staphylococcus aureus/growth & development/isolation & purification | Pathogenicity |
Metabolism | 21393142 | The minor groove-binding agent ELB-21 forms multiple interstrand and intrastrand covalent cross-links with duplex DNA and displays potent bactericidal activity against methicillin-resistant Staphylococcus aureus. | Rosado H, Rahman KM, Feuerbaum EA, Hinds J, Thurston DE, Taylor PW | J Antimicrob Chemother | 10.1093/jac/dkr044 | 2011 | Anti-Bacterial Agents/*metabolism/*pharmacology, Benzodiazepines/*metabolism/*pharmacology, Binding Sites, DNA/*metabolism, DNA Adducts/metabolism/pharmacology, DNA Repair/drug effects, Gene Expression Profiling, Gene Expression Regulation, Bacterial/drug effects, Methicillin-Resistant Staphylococcus aureus/*drug effects, Microarray Analysis, Microbial Viability/*drug effects, Protein Binding, Pyrroles/*metabolism/*pharmacology | Pathogenicity |
Enzymology | 21808542 | Wound healing properties and kill kinetics of Clerodendron splendens G. Don, a Ghanaian wound healing plant. | Gbedema SY, Emelia K, Francis A, Kofi A, Eric W | Pharmacognosy Res | 10.4103/0974-8490.62948 | 2010 | ||
Metabolism | 21880144 | Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection. | Paul VD, Sundarrajan S, Rajagopalan SS, Hariharan S, Kempashanaiah N, Padmanabhan S, Sriram B, Ramachandran J | BMC Microbiol | 10.1186/1471-2180-11-195 | 2011 | Animals, *Biological Therapy, Endopeptidases/genetics/metabolism, Humans, Male, Mice, Staphylococcal Infections/*microbiology/*therapy, Staphylococcus Phages/enzymology/genetics/*physiology, Staphylococcus aureus/physiology/*virology, Viral Proteins/genetics/metabolism, *Virus Release | Pathogenicity |
Metabolism | 22102735 | Formylated peptides are important virulence factors in Staphylococcus aureus arthritis in mice. | Gjertsson I, Jonsson IM, Peschel A, Tarkowski A, Lindholm C | J Infect Dis | 10.1093/infdis/jir713 | 2011 | Animals, Arthritis, Infectious/*immunology/microbiology/pathology, Chemotactic Factors/immunology, *Chemotaxis, Leukocyte, Female, Hindlimb/microbiology/pathology, Hydroxymethyl and Formyl Transferases/genetics, Interleukin-6/blood, Kidney/immunology, Mice, N-Formylmethionine Leucyl-Phenylalanine/*immunology, Neutrophils/*immunology, Peroxidase/metabolism, Staphylococcal Infections/*immunology/metabolism, Staphylococcus aureus/genetics/*immunology/*pathogenicity, Synovial Membrane/enzymology/immunology, Weight Loss | Enzymology |
Metabolism | 22155775 | Genes involved in immunity to and secretion of aureocin A53, an atypical class II bacteriocin produced by Staphylococcus aureus A53. | Nascimento Jdos S, Coelho ML, Ceotto H, Potter A, Fleming LR, Salehian Z, Nes IF, Bastos Mdo C | J Bacteriol | 10.1128/JB.06203-11 | 2011 | ATP-Binding Cassette Transporters/genetics/metabolism, Antimicrobial Cationic Peptides, Bacterial Proteins/chemistry/genetics/metabolism, Bacteriocins/chemistry/*genetics/*metabolism/pharmacology, Base Sequence, Escherichia coli/drug effects, Gene Expression, *Genes, Bacterial, Mutation, Open Reading Frames, Operon, Peptides/*genetics/immunology/*metabolism/pharmacology, Sequence Analysis, DNA, Staphylococcus aureus/*genetics/metabolism | Transcriptome |
Pathogenicity | 22178792 | Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: implications for diagnosis and pathogenesis. | Cheung GY, Duong AC, Otto M | Microbes Infect | 10.1016/j.micinf.2011.11.013 | 2011 | Bacterial Toxins/biosynthesis/chemistry/*metabolism, Hemolysin Proteins/chemistry/metabolism, *Hemolysis, Humans, Neutrophils/immunology/pathology, Sphingomyelin Phosphodiesterase/chemistry/metabolism, Staphylococcus aureus/chemistry/*pathogenicity, Staphylococcus epidermidis/chemistry/pathogenicity, Virulence | Metabolism |
Metabolism | 22380879 | Comparative expression analysis of two thermostable nuclease genes in Staphylococcus aureus. | Hu Y, Xie Y, Tang J, Shi X | Foodborne Pathog Dis | 10.1089/fpd.2011.1033 | 2012 | Bacterial Proteins/chemistry/genetics/*metabolism, Cell Proliferation, Enzyme Stability, *Gene Expression Regulation, Bacterial, Genetic Markers, Isoenzymes/chemistry/genetics/metabolism, Micrococcal Nuclease/chemistry/genetics/*metabolism, Mutation, RNA, Messenger/metabolism, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Species Specificity, Staphylococcus aureus/genetics/*growth & development/*metabolism | Enzymology |
Metabolism | 22685284 | The extracytoplasmic function sigma factor sigmaS protects against both intracellular and extracytoplasmic stresses in Staphylococcus aureus. | Miller HK, Carroll RK, Burda WN, Krute CN, Davenport JE, Shaw LN | J Bacteriol | 10.1128/JB.00484-12 | 2012 | Animals, Anti-Bacterial Agents/metabolism, Bacterial Proteins/*metabolism, Cell Line, Cell Wall/drug effects, DNA, Bacterial/drug effects, Gene Expression Profiling, *Gene Expression Regulation, Bacterial, Macrophages/immunology/microbiology, Mice, Microbial Viability, Promoter Regions, Genetic, Sigma Factor/*metabolism, Staphylococcus aureus/genetics/metabolism/*physiology, *Stress, Physiological | Pathogenicity |
Pathogenicity | 22982124 | Synthesis and antimicrobial evaluation of L-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4-thiazolidinone. | Jin X, Zheng CJ, Song MX, Wu Y, Sun LP, Li YJ, Yu LJ, Piao HR | Eur J Med Chem | 10.1016/j.ejmech.2012.08.026 | 2012 | Anti-Bacterial Agents/chemical synthesis/chemistry/*pharmacology, Chalcone/chemical synthesis/chemistry/*pharmacology, Dose-Response Relationship, Drug, Microbial Sensitivity Tests, Molecular Structure, Phenylalanine/chemistry, Rhodanine/chemical synthesis/chemistry/*pharmacology, Staphylococcus aureus/*drug effects, Structure-Activity Relationship, Thiazolidines/*chemistry, Thiobarbiturates/*chemistry | |
Enzymology | 23386262 | Detection and new genetic environment of the pleuromutilin-lincosamide-streptogramin A resistance gene lsa(E) in methicillin-resistant Staphylococcus aureus of swine origin. | Li B, Wendlandt S, Yao J, Liu Y, Zhang Q, Shi Z, Wei J, Shao D, Schwarz S, Wang S, Ma Z | J Antimicrob Chemother | 10.1093/jac/dkt015 | 2013 | Animals, Anti-Bacterial Agents/*pharmacology, China, Cloning, Molecular, DNA, Bacterial/genetics, Diterpenes/pharmacology, Drug Resistance, Bacterial/*genetics, Enterococcus faecalis/drug effects, Lincosamides/*pharmacology, Methicillin-Resistant Staphylococcus aureus/*genetics, Microbial Sensitivity Tests, Multilocus Sequence Typing, Plasmids/genetics, Polycyclic Compounds, Staphylococcal Infections/drug therapy/*microbiology/*veterinary, Streptogramin A/*pharmacology, Swine, Swine Diseases/drug therapy/*microbiology, Transformation, Bacterial | Pathogenicity |
Metabolism | 23541215 | Synergistic effects of diosmetin with erythromycin against ABC transporter over-expressed methicillin-resistant Staphylococcus aureus (MRSA) RN4220/pUL5054 and inhibition of MRSA pyruvate kinase. | Chan BC, Ip M, Gong H, Lui SL, See RH, Jolivalt C, Fung KP, Leung PC, Reiner NE, Lau CB | Phytomedicine | 10.1016/j.phymed.2013.02.007 | 2013 | ATP-Binding Cassette Transporters/*metabolism, Adenosine Triphosphate/metabolism, Anti-Bacterial Agents/*pharmacology, Diosmin/pharmacology, Dose-Response Relationship, Drug, Drug Synergism, Erythromycin/*pharmacology, Flavonoids/*pharmacology, Methicillin-Resistant Staphylococcus aureus/*drug effects/metabolism, Microbial Sensitivity Tests, Pyruvate Kinase/*antagonists & inhibitors | Pathogenicity |
Enzymology | 23555002 | Stably luminescent Staphylococcus aureus clinical strains for use in bioluminescent imaging. | Plaut RD, Mocca CP, Prabhakara R, Merkel TJ, Stibitz S | PLoS One | 10.1371/journal.pone.0059232 | 2013 | Animals, Bacteriophages/genetics, Chromosomes, Bacterial/*genetics, Electroporation, *Founder Effect, *Gene Transfer Techniques, Injections, Intravenous, Luminescence, Luminescent Measurements, Mice, Operon, Photorhabdus/chemistry/genetics, *Plasmids, Staphylococcal Infections/*microbiology/mortality, Staphylococcus aureus/*genetics/isolation & purification/ultrastructure, Survival Analysis | Phylogeny |
Pathogenicity | 23629701 | Novel erm(T)-carrying multiresistance plasmids from porcine and human isolates of methicillin-resistant Staphylococcus aureus ST398 that also harbor cadmium and copper resistance determinants. | Gomez-Sanz E, Kadlec K, Fessler AT, Zarazaga M, Torres C, Schwarz S | Antimicrob Agents Chemother | 10.1128/AAC.00171-13 | 2013 | Animals, Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics, Base Sequence, Cadmium/*pharmacology, Copper/*pharmacology, Drug Resistance, Multiple, Bacterial/genetics, Humans, Kanamycin/pharmacology, Membrane Proteins/genetics, Methicillin-Resistant Staphylococcus aureus/enzymology/*genetics/isolation & purification, Methyltransferases/genetics, Microbial Sensitivity Tests, Molecular Sequence Data, Oxidoreductases/genetics, Plasmids/drug effects/*genetics, Sequence Alignment, Sequence Analysis, DNA, Swine, Tetracycline Resistance/genetics, Tetracyclines/pharmacology, Trimethoprim Resistance/genetics | Enzymology |
Enzymology | 23639984 | Prevalence of fusB in Staphylococcus aureus clinical isolates. | Huang J, Ye M, Ding H, Guo Q, Ding B, Wang M | J Med Microbiol | 10.1099/jmm.0.058305-0 | 2013 | Adult, Aged, Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/*genetics, China/epidemiology, Drug Resistance, Bacterial/*genetics, Electrophoresis, Gel, Pulsed-Field, Fusidic Acid/*pharmacology, Humans, Male, Microbial Sensitivity Tests, Multilocus Sequence Typing, Mutation, Plasmids/genetics, Polymerase Chain Reaction, Prevalence, Sequence Analysis, DNA, Staphylococcal Infections/epidemiology/*microbiology, Staphylococcal Protein A/genetics, Staphylococcus aureus/classification/drug effects/*genetics/isolation & purification, Young Adult | Pathogenicity |
Genetics | 24098817 | Genetic variation in the Staphylococcus aureus 8325 strain lineage revealed by whole-genome sequencing. | Baek KT, Frees D, Renzoni A, Barras C, Rodriguez N, Manzano C, Kelley WL | PLoS One | 10.1371/journal.pone.0077122 | 2013 | Amino Acid Sequence, Base Sequence, Computational Biology, Genetic Variation/*genetics, Genome, Bacterial/*genetics, High-Throughput Nucleotide Sequencing/methods, INDEL Mutation/genetics, Molecular Sequence Data, Pedigree, Polymorphism, Single Nucleotide/genetics, Real-Time Polymerase Chain Reaction, Sequence Alignment, Sequence Analysis, DNA, Species Specificity, Staphylococcus aureus/*genetics | Transcriptome |
Genetics | 24324222 | Identification of a novel vga(E) gene variant that confers resistance to pleuromutilins, lincosamides and streptogramin A antibiotics in staphylococci of porcine origin. | Li J, Li B, Wendlandt S, Schwarz S, Wang Y, Wu C, Ma Z, Shen J | J Antimicrob Chemother | 10.1093/jac/dkt482 | 2013 | Animals, Anti-Bacterial Agents/*pharmacology, DNA, Bacterial/chemistry/genetics, Diterpenes/pharmacology, *Drug Resistance, Multiple, Bacterial, Genes, Bacterial, Lincosamides/*pharmacology, Microbial Sensitivity Tests, Molecular Sequence Data, Plasmids, Polycyclic Compounds, Sequence Analysis, DNA, Staphylococcus/*drug effects/*genetics/isolation & purification, Streptogramin A/*pharmacology, Swine, Transformation, Bacterial | Transcriptome |
Pathogenicity | 24338874 | Flavonoids from Sophora moorcroftiana and their synergistic antibacterial effects on MRSA. | Wang SY, Sun ZL, Liu T, Gibbons S, Zhang WJ, Qing M | Phytother Res | 10.1002/ptr.5098 | 2013 | Anti-Bacterial Agents/*pharmacology, Drug Synergism, Flavonoids/*pharmacology, Genistein/*pharmacology, Methicillin-Resistant Staphylococcus aureus/*drug effects, Microbial Sensitivity Tests, Molecular Structure, Plant Extracts/*pharmacology, Sophora/*chemistry | |
Enzymology | 24366733 | Identification of the novel lincosamide resistance gene lnu(E) truncated by ISEnfa5-cfr-ISEnfa5 insertion in Streptococcus suis: de novo synthesis and confirmation of functional activity in Staphylococcus aureus. | Zhao Q, Wendlandt S, Li H, Li J, Wu C, Shen J, Schwarz S, Wang Y | Antimicrob Agents Chemother | 10.1128/AAC.02007-13 | 2013 | Anti-Bacterial Agents/*pharmacology, Base Sequence, Cloning, Molecular, Drug Resistance, Bacterial/genetics, Genes, Bacterial/genetics, INDEL Mutation/genetics, Lincosamides/*pharmacology, Molecular Sequence Data, R Factors/chemical synthesis/*genetics, Sequence Alignment, Staphylococcus aureus/drug effects/*genetics, Streptococcus suis/drug effects/*genetics | Genetics |
Pathogenicity | 24641976 | Synthesis and antibacterial evaluation of amino acid-antibiotic conjugates. | Ibrahim MA, Panda SS, Birs AS, Serrano JC, Gonzalez CF, Alamry KA, Katritzky AR | Bioorg Med Chem Lett | 10.1016/j.bmcl.2014.01.065 | 2014 | Amino Acids/*chemistry, Anti-Bacterial Agents/chemical synthesis/chemistry/*pharmacology, Bacillus subtilis/drug effects, Dose-Response Relationship, Drug, Escherichia coli/drug effects, Metronidazole/chemical synthesis/chemistry/*pharmacology, Microbial Sensitivity Tests, Molecular Structure, Pseudomonas aeruginosa/drug effects, Quinolones/chemical synthesis/chemistry/*pharmacology, Staphylococcus aureus/drug effects, Structure-Activity Relationship, Sulfadiazine/chemical synthesis/chemistry/*pharmacology | |
Phylogeny | 24951306 | The Staphylococcal Cassette Chromosome mec type V from Staphylococcus aureus ST398 is packaged into bacteriophage capsids. | Chlebowicz MA, Maslanova I, Kuntova L, Grundmann H, Pantucek R, Doskar J, van Dijl JM, Buist G | Int J Med Microbiol | 10.1016/j.ijmm.2014.05.010 | 2014 | *Genes, Bacterial, Methicillin Resistance, Methicillin-Resistant Staphylococcus aureus/genetics/*virology, Plasmids, Prophages/*genetics/physiology, Staphylococcus Phages/classification/genetics, *Transduction, Genetic, *Virus Assembly | |
Pathogenicity | 25212982 | Combating against methicillin-resistant Staphylococcus aureus - two fatty acids from Purslane (Portulaca oleracea L.) exhibit synergistic effects with erythromycin. | Chan BC, Han XQ, Lui SL, Wong CW, Wang TB, Cheung DW, Cheng SW, Ip M, Han SQ, Yang XS, Jolivalt C, Lau CB, Leung PC, Fung KP | J Pharm Pharmacol | 10.1111/jphp.12315 | 2014 | Anti-Bacterial Agents/*pharmacology, Ciprofloxacin/pharmacology, Drug Synergism, Drug Therapy, Combination, Erythromycin/*pharmacology, Gas Chromatography-Mass Spectrometry, Linoleic Acid/chemistry/*pharmacology, Methicillin-Resistant Staphylococcus aureus/*drug effects, Microbial Sensitivity Tests, Oleic Acid/chemistry/*pharmacology, Plant Extracts/chemistry, *Portulaca | |
Enzymology | 25477024 | Enhancing DNA electro-transformation efficiency on a clinical Staphylococcus capitis isolate. | Cui B, Smooker PM, Rouch DA, Deighton MA | J Microbiol Methods | 10.1016/j.mimet.2014.11.012 | 2014 | Bacteremia/microbiology, DNA Restriction-Modification Enzymes/radiation effects, DNA, Bacterial/genetics, Electroporation/*methods, Genetic Vectors, Hot Temperature, Humans, Infant, Newborn, Staphylococcus/*genetics/isolation & purification/radiation effects, *Transformation, Bacterial | Stress |
Pathogenicity | 25600843 | Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates using a combination of delta-hemolysis assay and Etest. | Chang SC, Liu TP, Chen CJ, Lin LC, Lu JJ | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2014.12.006 | 2014 | Algorithms, Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/*analysis, Bacteriological Techniques/*methods, Carbon Dioxide/metabolism, *Drug Tolerance, Hemolysin Proteins/*analysis, Humans, Sensitivity and Specificity, Staphylococcus aureus/*classification/drug effects/*isolation & purification, Temperature, Time Factors, Vancomycin/*pharmacology | Phylogeny |
Enzymology | 26015493 | Complete Bypass of Restriction Systems for Major Staphylococcus aureus Lineages. | Monk IR, Tree JJ, Howden BP, Stinear TP, Foster TJ | mBio | 10.1128/mBio.00308-15 | 2015 | DNA Methylation, DNA Restriction-Modification Enzymes/genetics/metabolism, DNA, Bacterial/*genetics, Escherichia coli/genetics, Genetic Vectors, Mutation, *Plasmids, Staphylococcus aureus/*genetics, *Transformation, Bacterial | Metabolism |
26052549 | The Essential WalK Histidine Kinase and WalR Regulator Differentially Mediate Autolysis of Staphylococcus aureus RN4220. | Zheng L, Yan M, Fan F, Ji Y | J Nat Sci | 2015 | ||||
Pathogenicity | 26193939 | Compounds in a particular production lot of tryptic soy broth inhibit Staphylococcus aureus cell growth. | Ishii M, Matsumoto Y, Sekimizu K | Drug Discov Ther | 10.5582/ddt.2015.01030 | 2015 | Caseins/*pharmacology, Cell Proliferation/drug effects, Methicillin-Resistant Staphylococcus aureus/drug effects, Protein Hydrolysates/*pharmacology, Staphylococcus aureus/*drug effects/growth & development | Biotechnology |
Pathogenicity | 26453316 | In vitro activity of human and animal cathelicidins against livestock-associated methicillin-resistant Staphylococcus aureus. | Blodkamp S, Kadlec K, Gutsmann T, Naim HY, von Kockritz-Blickwede M, Schwarz S | Vet Microbiol | 10.1016/j.vetmic.2015.09.018 | 2015 | Animals, Anti-Bacterial Agents/pharmacology, Cathelicidins/isolation & purification/*pharmacology, Cattle, Drug Resistance, Bacterial/genetics, Humans, Methicillin-Resistant Staphylococcus aureus/*drug effects/genetics, Mice, Microbial Sensitivity Tests | Enzymology |
Metabolism | 27260167 | Dissecting the regulation of bile-induced biofilm formation in Staphylococcus aureus. | Ulluwishewa D, Wang L, Pereira C, Flynn S, Cain E, Stick S, Reen FJ, Ramsay JP, O'Gara F | Microbiology (Reading) | 10.1099/mic.0.000317 | 2016 | ATP-Binding Cassette Transporters/genetics, Aminoglycosides/pharmacology, Anti-Bacterial Agents/pharmacology, Bile/*metabolism, Biofilms/*growth & development, Cell Wall/*metabolism, Cystic Fibrosis/*microbiology/pathology, DNA Transposable Elements/genetics, Humans, Lung/microbiology/pathology, Microbial Sensitivity Tests, Protein Transport/genetics, Staphylococcal Infections/microbiology, Staphylococcus aureus/drug effects/*growth & development, Teichoic Acids/biosynthesis/*metabolism | Pathogenicity |
27298617 | Action of cholecalciferol and alpha-tocopherol on Staphylococcus aureus efflux pumps. | Tintino SR, Morais-Tintino CD, Campina FF, Pereira RL, Costa Mdo S, Braga MF, Limaverde PW, Andrade JC, Siqueira-Junior JP, Coutinho HD, Balbino VQ, Leal-Balbino TC, Ribeiro-Filho J, Quintans-Junior LJ | EXCLI J | 10.17179/excli2016-277 | 2016 | |||
27567890 | Efficient transformation of Staphylococcus aureus using multi-pulse electroporation. | Hisatsune J, Sato'o Y, Yu L, Kutsuno S, Hayakawa Y, Sugai M | J Microbiol Methods | 10.1016/j.mimet.2016.08.012 | 2016 | DNA, Bacterial/genetics, Electric Conductivity, Electricity, Electroporation/*instrumentation/*methods, Genetic Techniques/instrumentation, Plasmids, Staphylococcus aureus/*genetics, Temperature, *Transformation, Bacterial | ||
Pathogenicity | 28088472 | Cholesterol and ergosterol affect the activity of Staphylococcus aureus antibiotic efflux pumps. | Tintino SR, Oliveira-Tintino CD, Campina FF, Costa MS, Cruz RP, Pereira RL, Andrade JC, Sousa EO, Siqueira-Junior JP, Coutinho HD, Leal-Balbino TC, Balbino VQ | Microb Pathog | 10.1016/j.micpath.2017.01.019 | 2017 | Anti-Bacterial Agents/chemistry/*pharmacology, Cholesterol/chemistry/*pharmacology, Drug Antagonism, Ergosterol/chemistry/*pharmacology, Microbial Sensitivity Tests, Staphylococcus aureus/*drug effects/physiology | |
Pathogenicity | 28365326 | Inhibitory effects of flavonoids on biofilm formation by Staphylococcus aureus that overexpresses efflux protein genes. | Lopes LAA, Dos Santos Rodrigues JB, Magnani M, de Souza EL, de Siqueira-Junior JP | Microb Pathog | 10.1016/j.micpath.2017.03.033 | 2017 | Anti-Bacterial Agents/pharmacology, Bacterial Proteins/*genetics, Biofilms/*drug effects/growth & development, Flavonoids/administration & dosage/*antagonists & inhibitors/chemistry, Gene Expression Regulation, Bacterial/*genetics, Glycosylation/drug effects, Hesperidin/administration & dosage/antagonists & inhibitors/chemistry, Membrane Transport Proteins/genetics, Microbial Sensitivity Tests, Multidrug Resistance-Associated Proteins/genetics, Phloretin/administration & dosage/antagonists & inhibitors/chemistry, Phlorhizin/administration & dosage/antagonists & inhibitors/chemistry, Staphylococcus aureus/*drug effects/*genetics | |
Metabolism | 28588310 | The development of fluorescent protein tracing vectors for multicolor imaging of clinically isolated Staphylococcus aureus. | Kato F, Nakamura M, Sugai M | Sci Rep | 10.1038/s41598-017-02930-7 | 2017 | Bacterial Proteins/genetics/metabolism, Codon, *Fluorescent Antibody Technique, Gene Expression, Genes, Reporter, Genetic Vectors/*genetics, Green Fluorescent Proteins/genetics/metabolism, *Molecular Imaging, Mutation, Promoter Regions, Genetic, Staphylococcal Infections/*diagnosis/*microbiology, Staphylococcus aureus/*genetics/*metabolism | Phylogeny |
Phenotype | 28841421 | Tannic acid affects the phenotype of Staphylococcus aureus resistant to tetracycline and erythromycin by inhibition of efflux pumps. | Tintino SR, Morais-Tintino CD, Campina FF, Costa MDS, Menezes IRA, de Matos YMLS, Calixto-Junior JT, Pereira PS, Siqueira-Junior JP, Leal-Balbino TC, Coutinho HDM, Balbino VQ | Bioorg Chem | 10.1016/j.bioorg.2017.08.004 | 2017 | Anti-Bacterial Agents/chemistry/*pharmacology, Dose-Response Relationship, Drug, Drug Resistance, Bacterial/*drug effects/genetics, Erythromycin/chemistry/*pharmacology, Microbial Sensitivity Tests, Molecular Structure, Phenotype, Staphylococcus aureus/*drug effects/genetics, Structure-Activity Relationship, Tannins/chemistry/*pharmacology, Tetracycline/chemistry/*pharmacology | Pathogenicity |
Pathogenicity | 29253342 | Safe Staphylococcal Platform for the Development of Multivalent Nanoscale Vesicles against Viral Infections. | Yuan J, Yang J, Hu Z, Yang Y, Shang W, Hu Q, Zheng Y, Peng H, Zhang X, Cai X, Zhu J, Li M, Hu X, Zhou R, Rao X | Nano Lett | 10.1021/acs.nanolett.7b03893 | 2018 | Animals, Bacterial Proteins/*genetics, Cell-Derived Microparticles/*genetics, Dengue/*prevention & control, Dengue Vaccines/administration & dosage/*genetics/therapeutic use, Dengue Virus/*genetics, Gene Deletion, Humans, Mice, Mice, Inbred BALB C, Recombinant Fusion Proteins/genetics, Staphylococcus aureus/*genetics, Trans-Activators/*genetics, Viral Envelope Proteins/*genetics | |
29312199 | Construction of Stable Fluorescent Reporter Plasmids for Use in Staphylococcus aureus. | Rodriguez MD, Paul Z, Wood CE, Rice KC, Triplett EW | Front Microbiol | 10.3389/fmicb.2017.02491 | 2017 | |||
Pathogenicity | 29705276 | Biophysical evaluation of cardiolipin content as a regulator of the membrane lytic effect of antimicrobial peptides. | Hernandez-Villa L, Manrique-Moreno M, Leidy C, Jemiola-Rzeminska M, Ortiz C, Strzalka K | Biophys Chem | 10.1016/j.bpc.2018.04.001 | 2018 | Anti-Bacterial Agents/*pharmacology, Antimicrobial Cationic Peptides/*pharmacology, Cardiolipins/*chemistry, Cell Membrane/*chemistry/*drug effects, Microbial Sensitivity Tests, Staphylococcus aureus/*cytology/*drug effects | |
Enzymology | 29758246 | Creation of deletion and insertion clonal complex 8 Staphylococcus aureus mutants using a common cloning vector. | Chen P, Karna SLR, Leung KP | J Microbiol Methods | 10.1016/j.mimet.2018.05.008 | 2018 | Bacterial Proteins/genetics, Biofilms, DNA, Bacterial, Electroporation/methods, Exotoxins/genetics, Genes, Bacterial/genetics, *Genetic Vectors, Mutagenesis, Insertional/*methods, Plasmids, Pseudomonas aeruginosa/genetics, *Sequence Deletion, Staphylococcus aureus/*genetics | Pathogenicity |
Metabolism | 30149194 | Changes in resistance to and antimicrobial activity of antibiotics during in vitro human digestion. | Lee SY, Kim OY, Yoon SY, Lee DY, Hur SJ | J Glob Antimicrob Resist | 10.1016/j.jgar.2018.08.017 | 2018 | Anti-Bacterial Agents/*metabolism/pharmacology, Digestion, *Drug Resistance, Bacterial, Gastrointestinal Tract/*metabolism/*microbiology, Humans, Microbial Sensitivity Tests, Models, Biological, Ofloxacin/metabolism/pharmacology, Penicillins/metabolism/pharmacology, Staphylococcus aureus/*drug effects/growth & development, Tetracycline/metabolism/pharmacology | Pathogenicity |
Enzymology | 30176356 | Isovalerylshikonin, a new resistance-modifying agent from Arnebia euchroma, supresses antimicrobial resistance of drug-resistant Staphylococcus aureus. | He JM, Sun SC, Sun ZL, Chen JT, Mu Q | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2018.08.021 | 2018 | Animals, Anti-Bacterial Agents/administration & dosage/pharmacokinetics/*pharmacology, Boraginaceae/*chemistry, Drug Synergism, Mice, Microbial Sensitivity Tests, Naphthoquinones/administration & dosage/chemistry/pharmacokinetics/*pharmacology, Pentanoic Acids/administration & dosage/chemistry/pharmacokinetics/*pharmacology, Peritonitis/drug therapy/microbiology, Sepsis/drug therapy/microbiology, Staphylococcal Infections/*drug therapy/microbiology, Staphylococcus aureus/*drug effects | Pathogenicity |
Metabolism | 30518106 | Intracellular Accumulation of Linezolid and Florfenicol in OptrA-Producing Enterococcus faecalis and Staphylococcus aureus. | Wang Y, Li X, Wang Y, Schwarz S, Shen J, Xia X | Molecules | 10.3390/molecules23123195 | 2018 | *Drug Resistance, Bacterial, Enterococcus faecalis/*metabolism, Linezolid/*metabolism, Oxazolidinones/pharmacology, Species Specificity, Staphylococcus aureus/*metabolism, Thiamphenicol/*analogs & derivatives/metabolism | Phylogeny |
Pathogenicity | 30538695 | Characterization of the Multi-Drug Resistance Gene cfr in Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Isolated From Animals and Humans in China. | Li SM, Zhou YF, Li L, Fang LX, Duan JH, Liu FR, Liang HQ, Wu YT, Gu WQ, Liao XP, Sun J, Xiong YQ, Liu YH | Front Microbiol | 10.3389/fmicb.2018.02925 | 2018 | Phylogeny | |
Metabolism | 30942689 | Use of the counter selectable marker PheS* for genome engineering in Staphylococcus aureus. | Schuster CF, Howard SA, Grundling A | Microbiology (Reading) | 10.1099/mic.0.000791 | 2019 | Bacterial Proteins/*genetics/metabolism, Cloning, Molecular, Gene Knockout Techniques, *Genetic Engineering, Genetic Vectors/genetics/metabolism, Genome, Bacterial, Humans, Phenylalanine-tRNA Ligase/*genetics/metabolism, Plasmids/genetics/metabolism, Staphylococcal Infections/microbiology, Staphylococcus aureus/enzymology/*genetics/metabolism | Enzymology |
Pathogenicity | 31022566 | Capsaicin and gingerol analogues inhibit the growth of efflux-multidrug resistant bacteria and R-plasmids conjugal transfer. | Oyedemi BO, Kotsia EM, Stapleton PD, Gibbons S | J Ethnopharmacol | 10.1016/j.jep.2019.111871 | 2019 | Anti-Bacterial Agents/*pharmacology, Capsaicin/*pharmacology, Catechols/*pharmacology, Drug Resistance, Multiple, Bacterial/drug effects, Fatty Alcohols/*pharmacology, Microbial Sensitivity Tests, *R Factors, Staphylococcus aureus/*drug effects/growth & development | |
31195521 | Osmoadaptation by Staphylococcus aureus : Analysis of Several Strains Linked to Food Poisoning Outbreaks. | Louch HA, Eck ML, Miller KJ | J Food Prot | 10.4315/0362-028X-60.2.139 | 1997 | |||
Pathogenicity | 31231110 | Molecular characterization of multi-drug resistant coagulase negative cocci in non-hospital environment. | Nwibo DD, Panthee S, Hamamoto H, Sekimizu K | Drug Discov Ther | 10.5582/ddt.2019.01031 | 2019 | Anti-Bacterial Agents/pharmacology, Bacterial Proteins/genetics, Base Composition, Coagulase/metabolism, *Drug Resistance, Multiple, Bacterial, Genome Size, Microbial Sensitivity Tests, Staphylococcus capitis/drug effects/genetics/*isolation & purification, Staphylococcus haemolyticus/drug effects/genetics/*isolation & purification, Whole Genome Sequencing/*methods | Genetics |
Pathogenicity | 31307989 | The tva(A) Gene from Brachyspira hyodysenteriae Confers Decreased Susceptibility to Pleuromutilins and Streptogramin A in Escherichia coli. | Garcia-Martin AB, Schwendener S, Perreten V | Antimicrob Agents Chemother | 10.1128/AAC.00930-19 | 2019 | Animals, Brachyspira hyodysenteriae/*drug effects/*genetics, Diterpenes/*pharmacology, Drug Resistance, Bacterial/genetics, Escherichia coli/*drug effects/*genetics, Microbial Sensitivity Tests, Polycyclic Compounds/*pharmacology, Staphylococcus aureus/*drug effects/*genetics, Streptogramin A/*pharmacology, Swine, Swine Diseases/microbiology | |
Pathogenicity | 31388727 | Silviavirus phage MR003 displays a broad host range against methicillin-resistant Staphylococcus aureus of human origin. | Peng C, Hanawa T, Azam AH, LeBlanc C, Ung P, Matsuda T, Onishi H, Miyanaga K, Tanji Y | Appl Microbiol Biotechnol | 10.1007/s00253-019-10039-2 | 2019 | Genetic Variation, *Genome, Viral, *Host Specificity, Humans, Methicillin-Resistant Staphylococcus aureus/*virology, Phage Therapy, Sewage/virology, Staphylococcal Infections/therapy, Staphylococcus Phages/*genetics/isolation & purification/*physiology, Teichoic Acids/metabolism, Tokyo, Virus Attachment | Genetics |
Metabolism | 31548327 | In Staphylococcus aureus, the Particulate State of the Cell Envelope Is Required for the Efficient Induction of Host Defense Responses. | Kim B, Jiang T, Bae JH, Yun HS, Jang SH, Kim JH, Kim JD, Hur JH, Shibata K, Kurokawa K, Jung Y, Peschel A, Bae T, Lee BL | Infect Immun | 10.1128/IAI.00674-19 | 2019 | Animals, Cell Wall/*immunology, Chemokine CCL2/metabolism, Chemokine CXCL1/metabolism, Female, Immunity, Innate/immunology, Leukocyte L1 Antigen Complex/metabolism, Macrophages/immunology, Male, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Knockout, Monocytes/*immunology, Neutrophils/*immunology, Phagocytosis/immunology, Staphylococcal Infections/*immunology/microbiology, Staphylococcus aureus/*immunology | Pathogenicity |
32200127 | A class A beta-lactamase produced by borderline oxacillin-resistant Staphylococcus aureus hydrolyses oxacillin. | Nomura R, Nakaminami H, Takasao K, Muramatsu S, Kato Y, Wajima T, Noguchi N | J Glob Antimicrob Resist | 10.1016/j.jgar.2020.03.002 | 2020 | Anti-Bacterial Agents/pharmacology/therapeutic use, *Methicillin-Resistant Staphylococcus aureus/genetics, *Oxacillin/pharmacology, Staphylococcus aureus/genetics, beta-Lactamases/genetics | ||
32263116 | Synthesis, characterization and biological evaluation of a new photoactive hydrogel against Gram-positive and Gram-negative bacteria. | Spagnul C, Greenman J, Wainwright M, Kamil Z, Boyle RW | J Mater Chem B | 10.1039/c5tb02569a | 2016 | |||
Pathogenicity | 32419377 | Penicillin-binding protein PBP2a provides variable levels of protection toward different beta-lactams in Staphylococcus aureus RN4220. | Fergestad ME, Stamsas GA, Morales Angeles D, Salehian Z, Wasteson Y, Kjos M | Microbiologyopen | 10.1002/mbo3.1057 | 2020 | Anti-Bacterial Agents/*pharmacology, Bacterial Proteins/*genetics/metabolism, Drug Resistance, Bacterial/*genetics, Humans, Methicillin-Resistant Staphylococcus aureus/*drug effects/*genetics/isolation & purification, Microbial Sensitivity Tests, Microfluidics, Penicillin-Binding Proteins/*genetics/metabolism, beta-Lactams/*pharmacology | Metabolism |
Pathogenicity | 32449250 | MsrA Efflux Pump Inhibitory Activity of Piper cubeba L.f. and its Phytoconstituents against Staphylococcus aureus RN4220. | Ahirrao P, Tambat R, Chandal N, Mahey N, Kamboj A, Jain UK, Singh IP, Jachak SM, Nandanwar HS | Chem Biodivers | 10.1002/cbdv.202000144 | 2020 | Animals, Bacterial Proteins/*antagonists & inhibitors, Carbon-13 Magnetic Resonance Spectroscopy, Cell Line, Chromatography, High Pressure Liquid, Humans, Lignans/*pharmacology, Mass Spectrometry, Membrane Transport Proteins/*drug effects, Mice, Microbial Sensitivity Tests, Piper/*chemistry, Plant Extracts/*pharmacology, Proton Magnetic Resonance Spectroscopy, Staphylococcus aureus/*drug effects | |
Genetics | 32607281 | Whole-genome sequence analyses of Glaesserella parasuis isolates reveals extensive genomic variation and diverse antibiotic resistance determinants. | Wan X, Li X, Osmundson T, Li C, Yan H | PeerJ | 10.7717/peerj.9293 | 2020 | Transcriptome | |
32983054 | The Role of Amino Acid Substitution in HepT Toward Menaquinone Isoprenoid Chain Length Definition and Lysocin E Sensitivity in Staphylococcus aureus. | Panthee S, Paudel A, Hamamoto H, Uhlemann AC, Sekimizu K | Front Microbiol | 10.3389/fmicb.2020.02076 | 2020 | |||
Pathogenicity | 33127513 | Effect of estragole over the RN4220 Staphylococcus aureus strain and its toxicity in Drosophila melanogaster. | Bezerra AH, Bezerra SR, Macedo NS, de Sousa Silveira Z, Dos Santos Barbosa CR, de Freitas TS, Muniz DF, de Sousa Junior DL, Junior JPS, Donato IA, Coutinho HDM, da Cunha FAB | Life Sci | 10.1016/j.lfs.2020.118675 | 2020 | Allylbenzene Derivatives, Animals, Anisoles/administration & dosage/*toxicity, Anti-Bacterial Agents/administration & dosage/*toxicity, Dose-Response Relationship, Drug, Drosophila melanogaster, Drug Resistance, Multiple, Bacterial/*drug effects/physiology, Erythromycin/administration & dosage, Flavoring Agents/administration & dosage/toxicity, Microbial Sensitivity Tests/methods, Staphylococcus aureus/*drug effects/physiology | |
Pathogenicity | 33635515 | Inhibition of Staphylococcus aureus TetK and MsrA efflux pumps by hydroxyamines derived from lapachol and norlachol. | Figueredo FG, Parente RELT, Cavalcante-Figueredo MR, Figueiredo JG, da Silva RLP, Ferreira Matias EF, Silva TMS, Camara CA, de Morais Oliveira-Tintino CD, Tintino SR, Coutinho HDM, Fonteles MMF | J Bioenerg Biomembr | 10.1007/s10863-021-09885-5 | 2021 | Anti-Bacterial Agents/pharmacology/*therapeutic use, Naphthoquinones/pharmacology/*therapeutic use, Staphylococcus aureus/*drug effects | |
Metabolism | 33987904 | N-terminal acetylation of antimicrobial peptide L163 improves its stability against protease degradation. | Li D, Yang Y, Li R, Huang L, Wang Z, Deng Q, Dong S | J Pept Sci | 10.1002/psc.3337 | 2021 | Acetylation, Anti-Bacterial Agents/pharmacology, *Antimicrobial Peptides, Microbial Sensitivity Tests, *Peptide Hydrolases, Staphylococcus aureus | |
Enzymology | 33997506 | Multiplexed detection and differentiation of bacterial enzymes and bacteria by color-encoded sensor hydrogels. | Jia Z, Muller M, Le Gall T, Riool M, Muller M, Zaat SAJ, Montier T, Schonherr H | Bioact Mater | 10.1016/j.bioactmat.2021.04.022 | 2021 | ||
34001856 | ROS induces NETosis by oxidizing DNA and initiating DNA repair. | Azzouz D, Khan MA, Palaniyar N | Cell Death Discov | 10.1038/s41420-021-00491-3 | 2021 | |||
34069037 | Identification of the Multiresistance Gene poxtA in Oxazolidinone-Susceptible Staphylococcus haemolyticus and Staphylococcus saprophyticus of Pig and Feed Origins. | Chen L, Hu JX, Liu C, Liu J, Ma ZB, Tang ZY, Li YF, Zeng ZL | Pathogens | 10.3390/pathogens10050601 | 2021 | |||
34575478 | Hypericin and Pheophorbide a Mediated Photodynamic Therapy Fighting MRSA Wound Infections: A Translational Study from In Vitro to In Vivo. | Chan BCL, Dharmaratne P, Wang B, Lau KM, Lee CC, Cheung DWS, Chan JYW, Yue GGL, Lau CBS, Wong CK, Fung KP, Ip M | Pharmaceutics | 10.3390/pharmaceutics13091399 | 2021 | |||
Metabolism | 34878306 | Novel Tet(L) Efflux Pump Variants Conferring Resistance to Tigecycline and Eravacycline in Staphylococcus Spp. | Wang N, Li D, Schwarz S, Qin S, Yao H, Du XD | Microbiol Spectr | 10.1128/Spectrum.01310-21 | 2021 | Animals, Anti-Bacterial Agents/metabolism/*pharmacology, Bacterial Proteins/genetics/*metabolism, Disease Models, Animal, Drug Resistance, Multiple, Bacterial/genetics, Female, Genome, Bacterial/genetics, Mice, Mice, Inbred BALB C, Microbial Sensitivity Tests, Multigene Family/genetics, Pneumonia/microbiology, Protein Transport/*genetics, Sepsis/microbiology, Staphylococcal Infections/drug therapy, Staphylococcus aureus/drug effects/genetics/*metabolism, Swine, Swine Diseases/microbiology, Tetracyclines/metabolism/*pharmacology, Tigecycline/metabolism/*pharmacology, Whole Genome Sequencing | Genetics |
35625264 | Screening of Natural Molecules as Adjuvants to Topical Antibiotics to Treat Staphylococcus aureus from Diabetic Foot Ulcer Infections. | Oliveira D, Borges A, Saavedra MJ, Borges F, Simoes M | Antibiotics (Basel) | 10.3390/antibiotics11050620 | 2022 | |||
Pathogenicity | 35711812 | A Small Multihost Plasmid Carrying erm(T) Identified in Enterococcus faecalis. | Li XY, Yu R, Xu C, Shang Y, Li D, Du XD | Front Vet Sci | 10.3389/fvets.2022.850466 | 2022 | ||
Pathogenicity | 35745011 | Antibacterial and Oxidative Stress-Protective Effects of Five Monoterpenes from Softwood. | Muilu-Makela R, Aapola U, Tienaho J, Uusitalo H, Sarjala T | Molecules | 10.3390/molecules27123891 | 2022 | Anti-Bacterial Agents/pharmacology, Antioxidants/pharmacology, Escherichia coli, Humans, Hydrogen Peroxide/pharmacology, Microbial Sensitivity Tests, *Monoterpenes/pharmacology, *Oils, Volatile/pharmacology, Oxidative Stress | Stress |
Genetics | 35880893 | Bioinformatic Analysis of a Set of 14 Temperate Bacteriophages Isolated from Staphylococcus aureus Strains Highlights Their Massive Genetic Diversity. | Suarez CA, Carrasco ST, Brandolisio FNA, Abatangelo V, Boncompain CA, Peresutti-Bacci N, Morbidoni HR | Microbiol Spectr | 10.1128/spectrum.00334-22 | 2022 | Animals, *Bacteriophages/genetics, Cattle, Computational Biology, Genetic Variation, Genome, Viral, Humans, *Staphylococcal Infections/veterinary, Staphylococcus aureus/genetics | Pathogenicity |
Pathogenicity | 36037346 | Breaking down antibiotic resistance in methicillin-resistant Staphylococcus aureus: Combining antimicrobial photodynamic and antibiotic treatments. | Willis JA, Cheburkanov V, Chen S, Soares JM, Kassab G, Blanco KC, Bagnato VS, de Figueiredo P, Yakovlev VV | Proc Natl Acad Sci U S A | 10.1073/pnas.2208378119 | 2022 | Anti-Bacterial Agents/pharmacology, *Drug Resistance, Microbial/drug effects/radiation effects, Humans, *Methicillin-Resistant Staphylococcus aureus/drug effects/radiation effects, *Photochemotherapy, Photosensitizing Agents/pharmacology, Reactive Oxygen Species/pharmacology | |
Genetics | 36387480 | Hybrid assembly using long reads resolves repeats and completes the genome sequence of a laboratory strain of Staphylococcus aureus subsp. aureus RN4220. | Panthee S, Hamamoto H, Paudel A, Kaito C, Suzuki Y, Sekimizu K | Heliyon | 10.1016/j.heliyon.2022.e11376 | 2022 | ||
36465119 | An 11-year linezolid-resistant Staphylococcus capitis clone dissemination with a similar cfr-carrying plasmid in China. | Shen W, Chen J, Zhang R, Cai J | iScience | 10.1016/j.isci.2022.105644 | 2022 | |||
Biotechnology | 36472430 | Horizontal Transfer of Bacteriocin Biosynthesis Genes Requires Metabolic Adaptation To Improve Compound Production and Cellular Fitness. | Krauss S, Harbig TA, Rapp J, Schaefle T, Franz-Wachtel M, Reetz L, Elsherbini AMA, Macek B, Grond S, Link H, Nieselt K, Krismer B, Peschel A, Heilbronner S | Microbiol Spectr | 10.1128/spectrum.03176-22 | 2022 |
Reference
@id | authors | catalogue | doi/url | title |
---|---|---|---|---|
18922 | Curators of the DSMZ | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 26309) | https://www.dsmz.de/collection/catalogue/details/culture/DSM-26309 | |
20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | 10.1099/ijsem.0.004332 | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | |
66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |
68375 | Automatically annotated from API ID32STA | |||
87514 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | 10.60712/SI-ID405493.1 | StrainInfo: A central database for resolving microbial strain identifiers |